PIR Quiz-CME Credit

The American Academy of of Education. Elk Grove Village, IL 60009-0927. Pediatrics is accredited by the Ac- In addition, this course has PREP EDUCATION AWARD: creditation Council for Continuing been approved for 40 NAPNAP The PREP Education Award pro- Medical Education to sponsor con- contact hours. An individual re- vides recognition and support for tinuing medical education for phy- questing contact hours should those Academy Fellows and Candi- sicians. submit proof of participation and The American Academy of Pedi- verification of PREP accreditation date Fellows who participate in PREP. Individuals who qualify for atrics designates this continuing to the NAPNAP National Office. the PREP Education Award will medical education activity for 40 The questions for the PIR quiz credit hours in Category 1 of the are located at the end of each arti- receive their award automatically. To be eligible for this award, a Physician’s Recognition Award of dc in this issue. Each question has Fellow or Candidate Fellow of the the American Medical Association. a SINGLE BEST ANSWER. To American Academy of Pediatrics As an organization accredited for obtain credit, record your answers must receive, over a 3-year period, continuing medical education on the PIR Quiz Card found in the 150 hours of Category 1 CME (CME), completion of the PREP January issue, and return the card credits from the following sources: program meets the criteria for 40 to the Academy. (PREP group par- hours of credit toward the AAP ticipants will receive the PIR Quiz . 75 hours must be obtained from PREP Education Award. Card and Self-Assessment Credit participation in PREP (the Self- This program has been reviewed Reply Sheet under separate cover.) Assessment Exercise and/or and is acceptable for 40 Prescribed To receive CME credit on the i993 Pediatrics in Review) or PREP: hours by the American Academy annual credit summary, you must The Course. of Family Physicians. (Term of ap- be enrolled in PREP or subscribe . The balance (75 hours) of the proval: beginning date January to Pediatrics in Review and return 150 CME credits may be ob- 1993. Enduring materials are ap- the PIR Quiz Card by February 28, tamed through other programs proved for 1 year, with option to 1994. PIR Quiz Cards received sponsored or approved by the request renewal.) For specific in- after this deadline will be recorded Academy. This includes: the formation, please consult with the in the year they are received, with AAP Spring Session or Annual AAFP Office of Continuing Medi- cards from the 1993 PIR journals Meeting, CME courses, Acad- cal Education. accepted through December 31, emy-approved courses, or the This program has been reviewed 1995. Pediatric UPDATE audiocassette and is acceptable for 28 AOA Cat- The PIR Quiz card is bound into tape program. egory 2-B CME hours by the the January issue. Complete the The correct answers to the ques- American Osteopathic Association. quizzes in each issue and send it For specific information, please to: American Academy of Pediat- tions in this issue appear on the in- side front cover. consult with the AOA Department rics, PREP Office, P0 Box 927,

Pediatrics in Review VoL 14 No. 12 December 1993 495 CUMULATIVE AUTHOR INDEX

Pediatrics in Review Volumes 12 (1990-1991), 13 (1992), 14 (1993)

A

Alden, E.R., 12:131 Alpert, J.L., 12:375 Antonarakis, S.E., 13:138 Alderman, E. Meller, 13:314 Ament, M.E., 12:107 Arvin A.M., 13:107 Algranati, P.S., 13:16 Amin, S.B., 14:361 Atton, A.V., 12:25

B

Baker, R.B., 14:361 Berkowitz, C.D., 13:443; 14:324 Bradford, B.J., 14:281 Banez, G.A., 14:455 Berlin, C., Jr., 12:282 Brent, D.A., 14:380 Barness, L.A., 12:35 Bisett, T.C., 13:269 Brodeur, A.E., 12:196 Berera, G., 13:391; 14:191 Bithoney, W.G., 13:453 Brodeur, G.M., 12:196 Berg, S.L., 12:313 Boxer, L.A., 12:208 Burg, F.D., 12:11 Bergman D.A., 14:208 Bracikowski, A.C., 13:183; 14:433

C

Carroll, J.L., 14:51, 83 Clark, R.N., 12:149 Culbert, T.P., 14:455 Casey, P.H., 14:4 Cocalis, M.W., 14:273 Custer, J.R., 14:19 Chamberlin, R.W., 13:64 Cocores, J.A., 14:275 Cutting, G.R., 13:138 Chapman, D.D., 13:33, 157 Cohen, M.I., 13:314 Christensen, R.D., 12:244 Craig, C.L., 14:395

D

Davis, J.M., 12:136; 13:36 DiLiberti, J.H., 13:334 Duffy, L.F., 13:50 DeAngelis, C., 13:33, 295 Dixon, R.H., 13:391 Duncan, C.C., 14:389 Dehne, R., 12:268 Dow, J., 12:131 DuPont, R.L., 13:381 Devries, J.M., 14:361 Drutz, J.E., 13:125 Dworkin, P.H., 13:16 Dietz, WH., 14:337 Dubowitz, H., 13:453 Dyment, P.G., 12:103

E Erickson, L.C., 14:273 Egan, H., 13:453 Evans, W.E., 13:413 Emans S.J., 14:141 Evans, L.D., 14:4

F Fiser, D.H., 14:148, 163 Ferry P.C., 13:248 Freji, B.G., 12:227 Fischer, P.R., 14:95 Freeman, J.M., 13:298 Friedman, S.B., 12:218

G

Garber, R.M., 13:98 Goldberg, M.J., 14:395 Green, J.L., 13:295, 435, 469 Giardina, P.J., 13:55 Goldbloom, R.B., 13:183, 312 Greene, H.L., 13:185 Gilbert, W.L., 14:281 Goldman, D.A., 13:283 Greenstein, M.A., 13:334 Gittes E.B., 14:180 Gomez, M.R., 12:73 Grogan, D.P., 13:429 Glotzer, D., 13:461 Gottlieb, S.E., 12:218 Gryboski, J.D., 12:15 Gold, R., 12:292 Grant, L., 13:216

H

Haber, J.S., 12:305 Haka-Ikse, K., 14:401 Heiner, D.C., 14:226 Haggerty, R.J., 12:3, 5, 243, 291, 380; Hall, C. Breese, 14:335 Hellerstein, S., 14:70, 103 14:3 Healy, G.B., 13:23 Hilgartner, M.W., 13:55

496 Pediatrics in Review VoL 14 No. 12 December 1993 Holmes, L.B., 13:364 Hill, H.R., 12:298 Howie, V.M., 14:320 Hogan, P.A., 14:240 Hopwood, N.J., 14:481 Hurley, R.M., 12:167

I

Ingelfinger, J.R., 14:169 Irwin C.E., Jr., 14:180 Iseki M., 14:226

J

Jaffe, N., 12:333 Jones, K.L., 12:380 Jung F.F., 14:169 Joffe, A., 12:344

K

Katcher, A.L., 12:305 Kemper K.J., 12:181 Koch, W.C., 12:142 Kato, G.J., 12:171 Kendig, J.W., 13:262 Koenig, W.J., 13:391 Kay, M.H., 14:352 Klein, B.R., 13:127, 422 Krugman, R., 14:324 Kelch, R.P., 14:481 Kleinman, R.E., 14:123 Krugman, S., 13:203, 245 Kelsch, R.C., 14:30 Klish, W.J., 12:55

L

Lake, A.M., 14:475 Lawrence, R.A., 14:265 Loughlin, G.M., 14:51, 83 Lang, B.A., 14:194 Lease, J.G., 13:257 Lovejoy, F.H., Jr., 13:269, 273 Lanzkowsky, L., 13:130 Leventhal, B.G., 12:171 Lucey, J.F., 12:261 Lanzkowsky, P., 13:130 Liptak, G.S., 13:269; 14:117, 433 Lusher, J.M., 12:275 Lanzkowsky, 5., 13:130 Litt, I.F., 12:249 Lynch, S.K., 13:435

M

MacEwen, G.D., 12:268 McBride, J.T., 14:445 Miller, H.S., 14:281 Magill, F.B., 14:191 McCormick, M.C., 13:157 Miller, N.S., 14:275 Magramm, I., 13:7 Mclnerny, T.K., 12:69 Molteni, R.A., 12:47 Majer, L. Smith, 14:391 McLeod, H.L., 13:413 Morgan, J.P. 13:330; 14:101 Marcus, C.L., 14:51 Menna, V.J., 13:113, 363; 14:117, 433 Mortimer E.A., Jr, 13:98 Marino, E.R., 14:361 Mews, C. 14:436 Mulbury P.E., 12:213 Marsh, J.S., 14:297 Meyers, A., 14:371 Murphy, M.S., 12:325 Massey, G.V., 12:142 Mian, M., 14:401

N

Nass, R., 13:231 Nazarian, L.F. 13:75, 113, 123, 124, Nolan, T., 14:447 157, 213, 355, 469; 14:67, 207, 215, 299

0

Oberklaid, F., 14:447 Ogden J.A., 13:429 Oski, F.A., 12:187 Oberlander, T.F., 14:313 O’Gorman, M., 14:475 Overall, J.C., Jr., 14:251 Oblender, M., 14:191 Orenstein, S.R., 13:174

P

Pachman, L.M., 12:117 Pizzo, P.A. 12:5 Powers, N.G., 12:67 Pakula, L.C., 13:72 Poland, R.L., 14:262, 423 Pramanik, A.K., 13:163 Paradise, J.E., 13:216 Polanecsky, M.M., 13:43, 83 Prober C.G., 13:107 Patterson, M.C., 12:73 Poplack, D.G., 12:313 Putnam, T.C., 13:371

R

Radius, S.M., 12:344 Rapin, I., 14:43 Rasmussen, i.E., 13:152 Rand, T.H., 14:371 Rappaport, L.A., 14:313 Reiff, M.I., 14:455

Pediatrics in Review VoL 14 No. 12 December 1993 497 I ; -: - - ‘ - - I Risser, W.L., 14:424 Robinson, T.N., 14:337 Rosenthal, P., 12:67 Rivara, F.P., 12:181 Romero, R., 14:123 Roskos, R.R., 12:208 Rivera, J.A. 14:155 Rosen, F.S., 13:387 Rubenstein, J.S., 14:489 Robertson, W.O., 13:33, 113 Rosengren, S. Shulman, 13:334 S

Saenger, P., 12:355 Sever, J.L., 12:227 Smith, A.L., 14:11 Sahler, O.J., 12:6; 13:3; 14:331 Shackelford, P.G., 14:291 Smith, S., 13:435; 14:117 Saylor, K.E., 13:381 Shannon, M., 13:295 Soil, R.F., 12:261 Sayre, J.W., 13:269 Shapiro G.G., 13:403 Spinelli, H.M., 14:473 Schechter, N.L., 12:237 Sherry, D.D., 12:39 Starke, J.R., 13:343 Schonberg, S.K., 13:314 Silber, G., 12:85 Stein, R.E.K., 13:224 Schwartz, R.H., 14:101 Silverman, E.D., 14:194 Stevenson, R.J., 14:302 Sears, M.L., 13:127, 422 Sinatra, F.R., 12:67; 14:436 Stewart, C.L., 14:218 Sedman, A.B., 14:30 Sinkin, R.A., 12:136; 13:36 Strasburger, V.C., 13:144 Sehgal N., 14:215 Sklaire M.W., 12:69 Strong, W.B., 12:35; 13:379 Seidel J., 14:237, 284 Slap, G.B., 13:43, 83

T

Taubman B., 14:155 Tina, L.U., 14:218 Tunnessen, W.W., Jr., 12:25 Tejeda, D.M., 13:469 U

Udall, J.N., Jr., 13:185

V Vaughan, V.C., III, 13:88 Vandeven, A.M., 14:141 Virant, F.S., 13:323 Vane, D.W., 13:25 Vining, E.P.G., 13:305

w

Wald, E.R., 14:345 Watterberg, K.L., 14:262 Werner, M.J., 14:466 Walker W.A., 12:325 Weisman, S.J., 12:237 Wessell, M.A. 12:99, 163 Walsh-Kelly C.M., 14:155 Weitzman, M., 13:461 Weston, W.L., 14:240 Warner, I., 12:275 Weiliver J.R., 14:134 Woolf, A.D., 14:411 Wasserman, R.C., 13:4 Welliver, R.C., 14:134 Wyllie, R., 14:352 Y

Yamauchi T., 14:202 Yeager, A.M., 12:364 Young, R.S.K., 14:364

z

Ziegler, M.M. 14:302 Zuckerman, B., 12:375

498 Pediatrics in Review VoL 14 No. 12 december 1993 CUMULATIVE SUBJECT INDEX

The following index covers subjects in Pediatrics in Review in Volumes 12 (1990-1991), 13 (1992), and 14 (1993).

Each entry includes the volume and page number of the article in which the subject appears. (abs) = abstract Additionally, the index includes subjects addressed in the Self-Assessment (SA) Exercise for 1992 and 1993. Each entry includes the question number and year in which the subject appears.

A

Abdominal Acyclovir, 13:107 AIDS-see Acquired masses, 13:25, 129(abs) leukemia and, 12:313 immunodeficiency syndrome identification, 12:196 Addiction, 13:381 Alrway pain, 13:130; 14:313 Addison disease, 13:435 destruction, 14:19 acute, SA92:#285 Adenitis, cervical, 13:113; obstruction, 13:403; SA93:#280 bleeding and, 12:107 14:263(abs) upper, obstruction, sleep apnea chronic or recurrent, 14:67 Adenoid hypertrophy, SA92:#300 and, 12:373(abs) functional, 14:67; SA92:#144 Adenoidectomy, 14:320 Albumin and edema, 14:70 in children, 14:302 Adenoma sebaceum, vs acne, Alcohol, 13:381; 14:411 in cholecystitis, 14:155 SA93:#56 abuse, 13:314 in intussusception, 13:391 Adenosine deaminase deficiency, consumption during pregnancy in torsion of ovary, 13:183 14:226 (point-counterpoint), 12:375 referred, SA92:#191 Adenosine, in paroxysmal use, 13:144 recurrent, 13:397(abs) supraventricular tachycardia, Alkaline phosphatase, 13:471(abs) trauma, 13:238(abs) 14:273 Alkalosis, metabolic Abruptio placentae, 14: 1 16(abs) Adenovirus diuretic therapy, SA92:#1 70 Abscess clinical manifestations, 14:25 1; in pyloric stenosis, SA93:#226 brain, SA92:#17, #217 SA93:#1 21 Allergic contact dermatitis, children, peritonsillar, 13:74(abs) petechiae, 13:269 14:240 retropharyngeal, 12:113 Adjustment disorder, 14:380 Allergic rhinitis, 13:323; 14:444(abs) tubo-ovarian, 13:216 Adolescents, 13:224, 471(abs), Allergy, 13:312 Absence seizures, 13:305 472(abs); 14:380 additives, SA92:#1 66 Abuse, 13:443, 453 amaurosis fugax, 12:302(abs) dyes, SA92:#166 ofdrugs, 13:314 cause of death, SA93:#1 54 eggs, 14:245(abs) perpetrator, SA93:#21 7 compliance with medications, environmental trigger, SA93:#1 87 sexual, 13:443; 14:141, 401 SA93:#1 50 in infants, SA93:#69 Academic achievement, meningitis, health counseling, 12:344 insect stings, SA92:#1 67; 13:i12(abs) medicine, 13:216, 272(abs), 381 SA93:#21 8 Academic failure, 14:151(abs) pubertal and psychosocial late phase, SA93:#38 and drug abuse, 13:314 development, 12:249 nasal smear, SA93:#300 Accidental poisoning, 14:411 substance abuse, 13:314; penicillin, 14: 152(abs) Accutane, 13:364 SA93:#31 2 to cats, SA93:#1 59, #265 effects on fetus, 12:282 Adrenal insufficiency, 13:435; to cow milk, celiac disease and, Acetaminophen, 14:411 SA92:#62 12:325 Achievement tests, 14:455 Adrenarche, i4:336(abs) to food, SA93:#69 Achondroplasia, SA93:#1 49 premature pubarche, SA92:#1 11 unproven techniques, 12:22(abs) Acid-base equilibrium, 14:70 pubertal and psychosocial Alopecia Acidosis, 14:103 development, 12:249 areata, SA93:#102 electrolyte abnormalities, Adult respiratory distress syndrome, common causes, 12:25 SA92:#145; SA93:#161 14:148, 163 Alpha-1-antitrypsin, 14:436, 493(abs) metabolic, SA93:#1 61 Aeromonas, diarrhea, 13:97(abs) Alpha-fetoprotein, 13:334 renal tubular, 13:391; SA93:#222 Afebrile seizures, 13:305 significance of, SA93:#1 48 Acne, treatment of, SA92:#1 20 Affective illness, 14:380 Alport syndrome, 14:30, 43; Acquired immunodeficiency Agammaglobulinemia, 14:226 SA92:#43 syndrome, 14:180, 226, 371 infections in, SA93:#273 clinical findings, SA93:#80 hemophilia and, 12:275 treatment of, SA93:#252 Amanita phalloides, 14:411 in infants, i4:38(abs) Aganglionic megacolon, SA92:#21 2 Amantidine, side effects, SA93:#1 33 Acrocyanosis, vs central cyanosis, Aggression, 13:72; 14:214, 455 Amaurosis fugax, adolescents, SA93:#70 behavior, 13:144 12:302(abs) Acrodermatitis enteropathica, 13:157 children and adolescents, 12:218 Amblyopia, 13:7 Acute life-threatening event, 14:51 Aging out, 13:224

Pediatrics in Review Vol. 14 No. 12 December 1993 499 Ambulatory Care Quality Anoxia, 14:148 postinfectious, SA93:#34 Improvement Program (ACQIP), Anthropometry, 14:492 reactive, 12: 10(abs) 14:208 Antibiotic rheumatoid, limping and, 12:268 Amenorrhea, 13:43; SA92:#1 6, administration, SA93:#1 72 septic #210 prophylaxis, 13:355 limb pain, 12:39 Amino acids, supplements, 12:103 Antibody immunodeficiency, 14:226 limping and, 12:268 Aminoglycosides, 13:413 Anticonvulsant vs rheumatic fever, SA93:#1 20 uses of, SA93:#23 drugs, 13:305 Ascariasis, SA93:#1 15 Aminopenicillin (amoxicillin), fetal toxins, 13:364 Ascites, 14:436 SA92:#37 therapy, 13:75 Aspergillosis, 14:226 Aminotransferase, 14:436 Anticytoplasmic antibodies, systemic allergic bronchopulmonary, Amniocentesis, 13:334 lupus erythematosus, 14:194 SA92:#91 Amniotic fluid, suction, 13:237(abs) Antidiuretic hormone, inappropriate in cystic fibrosis, SA92:#91 Amoxicillin, sinusitis and, infants secretion of, 14:70; SA92:#38; Asphyxia and children, 12:2i7(abs) SA93:#238 CPR, in newborn, 12:136 Amphetamine, 13:273, 330; Anti-DNA titre, systemic lupus perinatal, SA92:#81 ; SA93:#104 14: lOi(point-counterpoint) erythematosus, 14:194 prenatal, SA93:#303 withdrawal, SA92:#42 Antidotes, 14:411 Aspirin, 13:273 Amphotericin B, 13:152 Antiepileptic drugs, 13:413 Asplenia, 14:226 Anal Antihistamines, 13:23, 387 Assessment fissures, 13:443 Antimicrobials, otitis media and, eight-week, 13:88 sphincter tone, 14:117 13:23 fifty-two-week, 13:88 Analgesia, pain management, 12:237 Antinuclear antibody, 13:130 five-year, 13:88 Anaphylactic reaction, penicillin, systemic lupus erythematosus, four-year, 13:88 14: i52(abs) 14:194 sixteen-week, 13:88 Anaphylaxis, 13:387 Antituberculous therapy, 14:263(abs) three-year, 13:88 insects, 14:246(abs) Anuria, 14:218 twenty-eight-week, 13:88 treatment of, SA92:#167 Anxiety, 13:381; 14:151(abs) twenty-four-week, 13:88 ANA-see Antibody, antinuclear Aorta, aneurysm, SA93:#216 Asthma, 13:214, 283, 403; 14:345, Androgen therapy, 13:5(abs) Aortic insufficiency, 14:272(abs) 444(abs) Anemia, 13:55, 461 Apgar score, 13:88, 262 airway obstruction in, SA93:#183 aplastic, clinical findings, one minute, CPR, newborn, 12:136 allergy and, SA93:#187, #265 SA93:#1 76 Aphthous ulcers, 14:475 and beta agonists, 14:489 aregenerative and aplastic, crisis, Aplasia, renal, SA92:#5 and beta blockers, 14:489 12:142 Aplastic crisis, 13:236(abs) exercise-induced, 13:474(abs); autoimmune hemolytic, 13:469 Apnea, 13:113, 116(abs), 174; SA93:#31 7 cystic fibrosis in, 13:183 14:51, 83, 100(abs), 445; SA93: late phase, SA93:#28 folic acid deficiency, SA92:#35 #61, #82 management in school, 14:391 hemolytic, 13:236(abs); sleep, upper airway obstruction pneumothorax, 13:398(abs) SA93:#139, #224 and, 12:373(abs) respiratory failure, SA92:#1 75 hypochromic, 13:55 Apophysitis, limping and, 12:268 symptoms of, SA93:#29 iron deficiency, 13:379; Appendicitis, 13:216 treatment of, SA93:#1 13, #296 SA92:#34 acute, 13:49(abs); SA92:#181 toxicity of, SA92:#208 macrocytic, 13:55; SA93:#192 evaluation by ultrasonography, triggers, SA93:#1 87, #265 perinatal, blood loss and, 12:47 i3:49(abs) Ataxia, 13:113 physiologic, 13:262; SA92:#308; in children, 14:302 telangiectasia, 14:226 SA93:#160, #236 Apple juice, and chronic diarrhea, Athlete’s heart, 13:151(abs) Anesthesia, neonatal, 12: 127(abs) 13:399(abs) Atlantoaxial Anger, 14:380 Arnold-Chiari dislocation, SA92:#1 47 Angioedema, 13:130, 387 malformation, SA93:#246 instability, 13:35(abs); SA92:#206 Animal bites, 13:394(abs) syndrome, 13: 1 16(abs) Atopy, 13:49(abs) Anion gap, 13:391; 14:103; Arrhythmia Atopic SA92:#1 56; SA93:#1 61 cardiac, 13:469; 14:273 dermatitis, SA93:#250, #261, calculating, SA92:# 137 surgical treatment of, 12:379(abs) #289 Aniridia, abdominal masses, 12:196 Arthralgia, limb pain, in childhood, treatment of, SA93:#126 Anismus, 14:447 12:39 disease, 13:312 Ankle, 13:429 Arthritis, 13:130 Atresia Ankylosing spondylitis, 14:117 complications of, SA92:#33 biliary, 14:436 Anorexia juvenile rheumatoid, SA92:#33; bowel, 13:50 in congestive heart failure, 14:35 1 SA93:#233 esophagus, 13:50 nervosa, 13:43; SA92:#16, #232, pauciarticular, SA92:#79; vaginal, 13: 129(abs) #252 SA93:#233 Atrioventricular canal, 14:488(abs)

500 Pediatrics in Review VoL 14 No. 12 December 1993 ::, ______

Attention deficit hyperactivity Atypical tuberculosis, 13:371 hemolytic anemia, 13:469 disorder, 13:37(abs); 14:455 Auditory Automobile children and adolescents, 12:218 acuity, tests, of, SA93:#31 0 accidents, 14:244(abs) therapy, SA93:#249 evoked potentials, 13:248 safety, SA92:#1 side effects of, SA92:#49 Autism, infantile, SA92:#1 85; Autonomic nervous system, 14:489 Attentional disorders, 14:455 SA93:#31 8 Autosomal inheritance, 13:138 Atypical mycobacterial Autoimmune Azathioprine, 14:475 lymphadenitis, 14:263(abs) disorders, 14:226 Azotemia, 14:103, 218

B

Back pain, in spinal cord lesions, Bites Brain tumor, and torticollis, 14:433 14:117 animal, 13:257; SA93:#243 Branhamella, 13:2.83 Back to Basics human, 13:257; SA93:#179 Breast autonomic nervous system, 14:489 Bladder dysfunction, 14:117 disorders, 13:74(abs) Bacteremia, 14:366(abs) Bleeding, 13:163 health counseling for adolescents, etiology of, SA93:#1 88 in hemophilia, 13:183 12:344 occult, SA93:#254 intramuscular, hemophilia and, self-examination, 13:74(abs) osteomyelitis, 12:292 12:275 Breastfeeding, 14:265 Bacterial vaginalis, 14:141 dysfunctional uterine, 13:43, 83 allergy, SA93:#69 BAL, lead, 13:461 rectal, SA93:#294 and drugs, SA92:#195 Barbiturates, 13:381 vaginal, SA92:#47 special infant formulas and, 12:55 overdose, 13:395(abs) Blindness, meningitis, 13: 1 12(abs) vitamin K deficiency and, Battery ingestion, 14:411 Blood 12:303(abs) Battle sign, 14:389; SA92:#55 loss, 13:36(abs) Breast milk, vitamin D-see Milk, Bayley test, 14:4 recombinant erythropoietin, 12:244 human Beclomethasone, 13:323 transfusions, in autoimmune Breath test, celiac disease and, Behavior hemolytic anemia, 13:469 12:325 adolescent, 12:218 Blood gases, capillary vs arterial, Breech presentation, 13:237(abs) antisocial, 12:218 SA92:#70 Bronchiectasis, SA92:#1 55; problems, 13:312 Blood pressure SA93:#31 6 Behavioral assessment, 14:455 adolescents, SA93:#302 Bronchiolitis, 14:134 Benzodiazepines, 13:381 newborn, 13:262; SA92:#134 Bronchopulmonary dysplasia Bereavement, SA93:#1 11 Blow-out fracture, 13:422 characteristics of, SA92:#1 53, Beriberi, 13:185 Body composition, 14:70 #266 Beta agonists, 13:403 Body mass, 13:396(abs) poor weight gain in, SA93:#143 Beta-hemolytic streptococcus, Bone age, 14:133(abs) radiographic findings in, 14:272(abs) growth hormone and short stature, SA92:#235, #266 Beta sympathetic 12:355 Bronchospasm, 13:403 agonists, 14:489 pubertal and psychosocial Bruising, 14:424 blockers, 14:489 development, 12:249 causes, 14:215 Bethanechol, gastroesophageal Bone aspiration, osteomyelitis conditions that mimic, 14:215 reflux, 13:198(abs) diagnosis, 12:292 in hemorrhagic disease of the Bicarbonate, 14:70 Bone lesions, in neurofibromatosis, newborn, 14:191 normal levels, SA92:#298 14:433 Bruxism, 13:16 Bicycle helmets, 13:276(abs) Bone marrow Buccal smear, SA93:#208 Bile salts, preterm, .14:123 failure, neonatal, 12:47 Bulimia Biliary atresia, SA93:#1 68 transplantation, 12:364 characteristics of, SA92:#1 72 Bilirubin, neonatal Bone tumor, 13:469 indications for hospitalization, hyperbilirubinemia (commentary), diagnosis, 12:292 SA92:#1 62 12:259 evaluation, 12:333 prognosis, SA92:#1 92 Bilirubinemia, 14:436 Botulism Bulk, dietary, SA92:#133 Biofeedback, 14:447 infantile, 14:117; SA92:#60 Burkitt lymphoma, childhood, Bipolar depression, 14:380 muscle disease, children, 12:73 12:171 Birth defects, 13:334 Bowel Bums, 13:257 Birth weight, low dysfunction, 14:117 degree, distinguishing features, mineral excretion and, i2:iOl(abs) training, 14:447 SA93:#21 2 special infant formulas, 12:55 Brachial plexus injuries, 13:77(abs) electrical, of face, SA93:#158 Brain electrical activity mapping, 13:248

Pediatrics in Review VoL 14 No. 12 December 1993 501 I . I C

Caf#{233}au lait spots, 14:433; orbital, SA92:#248, #286 Fitz-Hugh-Curtis syndrome and, SA93:#283 perianal streptococcal, 12:248(abs) 12:319 Calmette-Guerin bacillus, effect on periorbital, SA92:#1 88, #286 infection, cervicitis, treatment of tuberculin test, 13:343 Central apnea, 14:5 1 SA93:#225 Caloric requirements Central nervous system trachomatis, 13:443; 14:251 during infancy, SA92:#200 disease, 13:130 Chlamydial conjunctivitis, 14:423 preterm, 14:123 disorders of, 13:157 Chloramphenicol, 13:413 Camphor, 13:273 leukemia, 12:313 toxicity, SA93:#314 Cancer, 14:481 systemic lupus erythematosus, uses of, SA93:#314 hepatocellular, 13:203 14:194 Chlorhexadine, 13:283 liver, 13:203, 245 Cephalopelvic disproportion, Choanal atresia, SA93:#25 ofbone, 13:49 14: 1 16(abs) Choking, current first aid pediatrician and (commentary), Cephalosporin, first generation, recommendations, 12:54(abs) 12:5 SA92:#65, #218 Cholangitis, 14:436 Candida, HIV, 14:371 Cerebral cavernous malformation, Cholecystitis, 14: 155, 302; Candidal infection incidence and occurrence, SA92:#1 57 during infancy, SA93:#3 i2:24(abs) Choledochal cysts, 14:302 in immunocompromised, Cerebral palsy, 12:73; SA92:#81, Cholelithiasis, 14:313; SA92:#1 57 SA93:#92 #108 Cholestasis, neonatal, SA93:#1 68 Candidiasis, 13:152; 14:141 seizures, 13:305 Cholesteatoma, 14:320; SA93:#21 1 Cannabis, 14:466 Cerebrospinal fluid Cholesterol, 13:471 (abs) Cannulation, 13:239(abs) examination, contradindications, Chorionic villus sampling, 13:334 Car seats, 14:244(abs) SA92:#245 Chorioretinitis, toxoplasmosis and, Carbamazepine, effects on fetus, in meningitis, SA93:#85 12:227 12:282 obstruction, 13:295 Chromosome Carbohydrate intolerance, Cerebrovascular accidents, 13:379 translocation, SA92:#40 i3:437(abs); 14:313 Cervical spine malformations, and 22, i3:197(abs) Carbon dioxide, sleep, i3:473(abs) torticollis, 14:433 Chromosomal disorders, Klinefelter Carbon monoxide, 13:273 Cervicitis, 13:216; 14:180 syndrome, 13:435 Carboxyhemoglobin, 13:295 Cervix, cancer, sexually transmitted Chronic active hepatitis, 13:245 Cardiac arrhythmias, 13:469; 14:273 diseases and, 12:383(abs) Chronic cough, 13:49(abs), 403 Cardiogenic shock, 13:358(abs) Charcoal, 14:411 Chronic granulomatous disease, findings in newborn, SA93:#89 Chelation, 13:55 14:226 signs and symptoms, SA93:#129 Chaperones, 13:272(abs) Chronic illness, 13:224; 14:380 Cardiomyopathy Chediak Higashi syndrome, 14:226 and discipline, SA93:#86 dilated, 14:361 Chemical injuries, eyes, 13:422 Chronic nonspecific diarrhea, hypertrophic, 14:361 Chemoprophylaxis, meningitis, 13:397(abs) Cardiopulmonary resuscitation, 13:370(abs) Cigarette smoke, passive, newborns 12: 136 (commentary); Chemotherapy 14:444(abs) 13:36 osteosarcoma, 12:333 Cimetidine, peptic ulcer disease and, Carditis, 14:272(abs) pediatrician and (commentary), 12:15 Cat scratch disease, 13:371; 12:5 Circumcision, 13:163 SA93:#231 Chest pain, pneumothorax, bleeding, 12:275 Cataracts, 13:7 13:398(abs) Cirrhosis, 13:203, 245; 14:436 Catecholamines, Chest roentgenograms, 13: 196(abs) Clavicle fracture, 13:262 urinary, identification of Chest wall trauma, 14:237 Cleft palate, management, abdominal masses, 12:196 Child abuse, 13:257 SA93:#1 78 Cathartics, 14:411 bruising in, 14:215 Clonidine, 13:381 Caustics, 14:411 fractures in, 14:215; SA92:#138; Clostridium difficile, SA93:#48, #7E CD4 lymphocytes, 14:371 SA93:#217, #306 Clotrimazole, 13:152 Cefotaxime, 14:11 physical abuse, SA92:#1 38 Clubfoot, 14:395; SA92:#64 Ceftriaxone, 14:11 prevention, 13:64 Clumsiness, neurologic signs, Celiac guidelines, 12:304(abs) SA92:#107 disease, differential diagnosis, Child sexual abuse, 14:141 Coagulation disorders, 13:163 12:325 Childhood Cocaine, 13:273, 364 sprue, SA93:#235 asthma, 13:403 abuse, 14:361 Cell-medicated immunodeficiency, intoxications, 14:411 effects on fetus, 12:282; 14:226 poisoning, 14:411 SA92:#99 Cellulitis, 13:257 Children, 14:380 overdose, 14:361 extremity, SA92:#65 Chiamydia, 14:180

502 Pediatrics in Review VoL 14 No. 12 December 1993 I I Cognitive The satisfactions of pediatric otitis media, 13:23 development, 13:88 practice, 12:99 polycythemia with congenital heart impairment, 13:461 “The second new year” 14:3 disease, 13:379 problems, 14:4 The value of recording telephone screening for scoliosis, 14:297 Coining, as a cause of bruising, contacts, 12:372 sepsis in the newborn, 14:262 14:215 Common variable immunodeficiency, skull fractures in infancy and Cold stress, 13:262 14:226, 291 childhood, 14:389 “Cold” urticaria, 13:387 Community programs, 13:64 sibling rivalry, 13:72 Colds, 13:283 Compartment syndrome, in snoring, 14:445 Colic, 13:16 hemophilia, 13:183 unknown poison, 13:273 pain, 14:302 Complement Consumptive coagulopathy, 13:269 Colitis, 14:475 deficiency, 14:226 Contact lower gastrointestinal bleeding, systemic lupus erythematosus, dermatitis, 24:240 12:85 14:194 lenses, 13:422 Colonoscopy, 14:352 Compliance, 13:224 sports, SA92:#53 Colostrum, 14:265 barriers to, 13:224 Contraception, 13:216 composition of, SA93:#1 82 Comprehensive services, 13:64 risks of, SA93:#293 Coma Computed tomography, 13:238(abs) Contraction stress test, SA93:#30 impending signs of, SA92:#48 cranial, 13:248 Conversion reaction, SA92:#256 neuron-specific enolase in, neurology, 13:248 Convulsions, afebrile, 13:305 12:3 12(abs) Concussions, 14:424 Coordination, 13:224 Commentaries Conduct disorders, 14:380 Copper, preterm, 14:123 A rare and special privilege, children and adolescents, 12:218 Cor pulmonale, 13: 1 16(abs), I 3:123 Conductive hearing loss, 14:43 473(abs); 14:445 Caring for the child with cancer Condyloma acuminata, 13:443; electrocardiographic criteria for, and the family: Lessons learned 14:180 SA93:#239 from children with acute treatment of, SA93:#9 Corneal injuries, 13:422 leukemia, 12:6 Congenital Corticosteroids, 13:403; SA93:#76 Editor and editorial office move, adrenal hyperplasia, 14:336(abs) in autoimmune hemolytic anemia, 13:243 deafness, 14:43 13:469 Guides for record review, 12:131 ear deformity, 14:473 Cosleeping, SA93:#253 Hospital management of indirect heart disease, i3:358(abs) Cough, i3:438(abs); 14:345 neonatal hyperbilirubinemia by infection, associated conditions of, chronic, SA92:#203; SA93:#29 the office-based physician, SA93:#1 1 in congestive heart failure, 14:361 12: 259 scoliosis, 14:297 medicine, 14:264(abs) Immunization for hepatitis B syphilis, 13:262 Counseling infection, 14:335 Congestive heart failure, 13:33; health, adolescents, 12:344 Inpatient care: The general 14:361 violence, 12:68(abs) pediatrician’s future, 12:165 diagnosis of, SA93:#1 62 Couramin, rifampin, i3:354(abs) “Lethargic” and other adjectives, signs of, 14:361 Cover test, strabismus, 13:7 13 :363 Conjunctivitis, SA92:#26 Cow milk, 14:265 On consulting and being consulted, and otitis media, SA92:#26 protein allergy, 14:123 13:124 Consent Coxa valgus, 14:395 1-800: please admit, 12:195 for treatment, SA92:#128 Coxa varus, 14:395 Pediatrician’s response to a informed, SA92:#1 28 Coxsackie virus, 14:251; SA93:#282 stillbirth or death of a neonate, Constipation, 14:447 Cranial ultrasonography, 13:248 12:163 and Hirschsprung disease, 13:25; Craniosynostosis, SA93:# 177 Pickles, pizza, and PREP, 13:3 SA92:#21 2 Crohn disease, 14:352, 475 PREParation for PRCP, 14:331 dietary management, SA92:#1 33 treatment of, SA93:#1 6 Quality improvement: doing it irritable bowel syndrome, Cromolyn sodium, nasal, 13:323 right, 14:207 13:397(abs) Cross-infection, 13:283 Reviewing the pediatrician’s Consultation with the specialist Cromolyn, 13:403 personal medical records, allergy, 13:312 Croup, 14:19 12: 133 behavior, 13:312 diagnosis of, SA93:#280 Screening for vision problems in chest trauma in children, 14:237 Crying, 13:16 pediatric practice, 13:4 congenital ear deformities, 14:473 Cupping, as a cause of bruising, The pediatric hospital consultant, disorders of the spinal cord, 14:215 13:125 14:364 Cushing The pediatrician and the care of enterococcal infections, 14:202 syndrome, SA93:#1 22 children with malignancy, 12:5 eye injury, 13:127 tumor, 14:169 The role of the pediatrician in eye prophylaxis in the newborn Cyanosis school health, 12:69 infant, 14:423 acute SA92:#71

Pediatrics in Review Vol. 14 No. 12 December 1993 503 I : ‘ :-- -:.:y:i4. I blood gases in, SA93:#256, #290 gastroesophageal reflux and infant, Cystitis, treatment of acute, central vs acrocyanosis, SA93:#70 12:371(abs) SA92:#71 Cyanotic heart disease, 13:379; hypoalbuminemia and, 12:384(abs) Cystourethrography, 13:279(abs) SA92:#169; SA93:#51 nasal polyps in, SA93:#245, Cytokines, transfusion, neonates, Cyclosporin A, 14:475 #287 12:298 Cystic fibrosis, 13:73(abs), 116(abs), neonatal manifestations, Cytomegalovirus infection, 13:107, 183, 185, 278(abs); 14:345, 436 SA92:#221 283; 14:371 antibiotic therapy in, SA93:#257 treatment of, SA93:#257 acquisition of, SA92:#51; diagnosis of, SA92:#61 vitamin K deficiency, 12:84(abs) SA93:#260 dietary management of, Cystinosis, ophthalmologic breast milk and, SA93:#260 SA92:#222 manifestations, SA93:#1 08 congenital, manifestations of, frequency of, SA92:#7 SA93:#1 1

D

Day care, 13:283 cognitive, SA93:#33, #186, #213 DiGeorge syndrome, 13:197(abs); chemoprophylaxis, 13:370(abs) fine motor, SA92:#186, #261; 14:226 infections, 13:354(abs) SA93:#1 36 Digestion, low birth weight, 14:123 Deafness, 14:11, 43 gross motor, SA92:#284 Digoxin, 13:413; SA93:#119 and language, SA92:#272 infants, SA92:#1 09, #261 , #284 Diphtheria-tetanus toxoids with congenital, SA92:#288; intelligence quotient and, pertussis SA93:#1 56 SA93:#286 immunization schedule, in osteogenesis imperfecta, 14:215 language, SA92:#83, #272, SA92:#54, #96 Death #288; SA93:#33, #55 reactions to vaccine, SA93:#201 auto accidents, 14:244(abs) learning, SA92:#250; SA93:#33, risks, 12:125(abs) causes in adolescents, SA93:#1 54 #207 Dipstick test, 14:30 children’s reactions to, SA93#1 Ii plateau or regression in central Disability, 13:224 drowning, SA93:#35 nervous system disorders, developmental, early intervention, Decongestants, 13:23 13:157 12:305 topical toilet training, SA93:#299 visible, 13:224 infants, SA92:#266 Dextrostix, 13:262 Discharge plans, newborns, 13:262 side effects of, SA92:#266 Diabetes insipidus, SA92:#296 Discitis, limping and, 12:268 Dehydration, 14:103 head trauma, SA92:#296 Disease prevention, health counseling hypernatremic nephrogenic, SA92:#230 for adolescents, 12:344 manifestations of, SA92:#1 84 Diabetes mellitus, 13:278(abs), 364 Disqualification, sports, 14:424 neurologic effects of, glycosylated hemoglobin in, Disseminated intravascular SA93:#268 SA92:#234 coagulation, 13:163 hypertonic, SA92:#1 84 insulin types, SA93:#227 disorder, 13:269 hyponatremic, treatment of, Diarrhea; 13:283; 14:95, 251, 284, hemophilia and, 12:275 SA92:#225 312(abs) Diuretic therapy hypotonic, SA92:#225 bloody, 13:97(abs) electrolytes, effects on, Delinquency, 14:214(abs) Campylobacterjejuni, SA92:#1 70, #304; SA93:#202 Dental procedures, prophylaxis, SA93:#193, #277 nephrotic syndrome, 14:30 SA92:#68 Clostridium diffidile toxin, ototoxicity, SA92:#1 16 Depressants, 13:381 SA93:#291 DMSA treatment, lead, 13:461 Depression, 14: 15 i(abs), 214(abs), chronic, 13:397(abs); SA93:#191 Doctor-patient communication, health 380 celiac disease and, 12:325 counseling for adolescents, 12:344 children and adolescents, 12:218 nonspecific, 13:399(abs) Dolls, anatomically correct, 13:443 drug abuse, 13:314 dehydration, 14:103 Dopamine, 14:489 maternal, developmental disability in acrodermatitis enteropathica, blockers, SA93:#204 and, 12:305 13: 157 Down syndrome, 13:35(abs), 334; Dermatitis, 14:240 inflammatory bowel disease, 14:488(abs) atopic, SA93:#261 14:475 atlantoaxial dislocation in, Dermatomyositis, juvenile, 12:117 lactose intolerance, 13:437(abs) SA92:#147, #206 Dermoid cysts, 13:371 oral rehydration for, SA93:#291 developmental disabilities, early Desensitization, 13:387 Diazepam intervention, 12:305 Desferrioxamine, 13:55 rectal administration of, 13:413 growth with, 12: 164(abs) Desmopressin, hemophilia and, for febrile seizures, 13:298 life expectancy, 12:71(abs) 12:275 human milk, 13:413 recurrence of, SA92:#85 Development, 14:4, 123; Dideoxyinosine, HIV, 14:371 Drowning, 14:148 SA93:#286 Diet, 13:312 hypothermia, SA92:#249 Bayley scales, SA92:#20 diarrhea, 13:399(abs) mortality from, SA93:#35

504 Pediatrics in Review VoL 14 No. 12 December 1993 I#{149}. near, 14:148 therapy, fetal effects, 12:282 Duck embryo vaccine, rabies, management of, SA92:#21 1 treatment programs, 13:3 14 i4:280(abs) Drug abuse, 13:314 Drugs Duplication of intestine, 13:50 cocaine, effects on fetus, 12:282 anticonvulsants, SA93:#274 Dust mites, management of, conduct disorders and children and breast milk, 14:265 SA93:#1 87 adolescents, 12:218 effects on learning, SA93:#301 Dwarfism, congenital, dysplasias hallucinogens, SA93:#84 nonsteroidal anti-inflammatory, and, 12:149 heroin, SA92:#198 SA92:#1 73 Dyskeratosis congenita, clinical maternal phenobarbitol, interactions with, disorders of neutropenia, 12:208 effects on fetus, 12:291 SA93:#275 Dyslexia, 13:231; 14:455; evaluation by pediatrician, steady state, SA93:#7 SA92:#265 12:11, 282 stimulants, SA92:#49 Dysmenorrhea, 13:83 screening, i2:207(abs) testing, in urine, SA93:#12 following pelvic inflammatory smokeless tobacco, i2:297(abs) theophylline, half-life of, SA93:#7 disease, 13:216 Drug tricyclic antidepressants, Dysmorphology, 13:364 dependence, 13:381 SA92:#268 Dyspepsia, 14:313; SA92:#267 hypersensitivity, 13:387 Drug-protein binding, theophylline, Dysplasias ingestion, alcohol and, SA92:#18 SA93:#21 9 bronchopulmonary-see interactions, 13:113 Duane syndrome, 13:7 Bronchopulmonary dysplasia phenobarbitol, SA93:#1 12 Duchenne muscular dystrophy, congenital dwarfism and, 12:149 prevention and public advocacy children, 12:73 Dysthymia, 14:380 initiatives, 13:314 diagnosis of, SA93:#1 53 Dysuria, 13:443 testing, 13:314

E

Ear malformations, 14:473; HIV, 14:371 Epinephrine, 14:489 SA93:#1 42 Encopresis, 14:447; SA92:#9, #45 Epiphysis Eczema Endocardial cushion defect, fractures, 13:429 characteristics of, SA92:#87; i4:488(abs) slipped capital femoral, 13:157 SA93:#289 Endocarditis limping and, 12:268 treatment of, SA93:#1 26 etiology of, SA92:#283 Epistaxisnasal septum hematoma, Ectopic pregnancy, 14:302 prophylaxis for, SA92:#68 13:275(abs) pelvic inflammatory disease, subacute, SA92:#283 recurrent, 12:213 14:180 Endometriosis, 13:83 EPSOT-lead screening, 13:461 Edema, 14:30, 70 Endometritis, 13:216 Epstein-Barr virus, 12: 107; 14:251 in cystic fibrosis, 13:183 Endoscopy, gastrointestinal bleeding, infection, SA93:#1 47 EDTA, penicillamine, 13:461 14:352 neurologic complications, Education, alternative placement, Energy requirements, preterm, SA92:#63 SA93:# 123 14:123 transmission, SA93:#60 Education for All Handicapped Enolase, neuron-specific, 12:3i2(abs) Erb palsy, i3:77(abs) Children Act (PL94-i42), Enterococcal infections, 14:202 Erythema SA93:#229 Enterocolitis, lower gastrointestinal infectiosum, i3:236(abs) Educational intervention, bleeding, 12:85 nodosum, 14:475 developmental disabilities, 12:305 Enterovirus, petechiae, 13:269 toxicum, SA92:#307 Effusion, pleural, SA92:#239 Enuresis, nocturnal and diurnal, Erythroblastosis, 13:334 Egg allergy, i4:245(abs) differences, 12:167 Erythrocytes, recombinant Elbow, dislocation, SA93:#2 Environmental hazards, 13:461 erythropoietin, 12:244 Electrocardiogram, in cor pulmonale, Eosinophils, nasal smears, Erythromycin, SA93:#1 13:473(abs); SA93:#239 SA93:#300 ophthalmic ointment, 14:423 Electroencephalography, 13:248 Epicutaneous testing, 14:240 pertussis, 13:438(abs) Electrolytes, 14:70 Epidemiology, 13:283 Erythropoiesis, erythropoietin role in, in status epilepticus, SA93:#1 5 Epididymitis, 14:180 12:244 ELISA test, HIV, 14:38(abs) Epidural abscess, 14:364 Erythropoietin, recombinant, Emancipated minors, SA92:# 128 Epiglottitis, 14:19, 281 advances, 12:244 Encephalitis in young adult, 14:281 Erythroprotoporphyrin test, 13:461 characteristics of, SA93:#83 Epilepsy, 13:75, 305 Escherichia coli, enterotoxigenic, enterovirus, SA93:#230 absence seizures, SA93:# 103 SA92:#8 herpes, 13:107 and febrile seizures, 14: 190(abs) Esophageal measles, SA93:#240 infantile spasms, SA93:#4 atresia, SA92:#1 39 Encephalopathy treatment of, SA92:#274; injury, SA92:#46 hepatitis, 14:436 SA93:#181, #274 varices, 14:436; SA92:#5

Pediatrics in Review VoL 14 No. 12 December 1993 505 I - -;‘ - : .- - -, ,-‘ - . ; - - I

upper gastrointestinal bleeding, Evaluation, learning disability, in congestive heart failure, pediatric patient, 12:107 14:213(abs) 14:361 Esophagitis, 13:174; 14:352 Ewing sarcoma, 13:469 Exostosis, 13:371 corrosive, SA92:#1 14 evaluation, 12:333 Extracellular fluid, 14:70 Esophagus, foreign body, limping and, 12:268 Eye SA93:#264 Excision, surgical, 14:263(abs) fixation, newborn, 13:262 Ethanol, 13:273 Exercise goggles, 13:422 intoxication, SA92:#18 infants, i2:95(abs) injuries, 13:422 intolerance, i3:474(abs) prophylaxis, newborn, 13:262

F

Failure to thrive, 13:391, 453; Fever, 14:251 eyes, 13:422 14:226, 371 leukemia and, 12:313 ingestion, SA93:#264 celiac disease and, 12:325 meningococcemia, 13:269 nasal, SA93:#304 renal causes of, SA93:#222 Fibrous dysplasia, 13:371 tracheal, 14: 19; SA93:#285 Family factors, drug abuse, 13:314 Fifth disease, 13:236(abs) vaginal, 14:141 Family support services, 13:64 Fine motor development, 13:88 Foreskin entrapment, 14:140 Fanconi syndrome, clinical disorders First aid, choking, current Formula of neutropenia, 12:208 recommendations, 12:54(abs) amino acids in, SA93:#45 Fansidar, 14:95 Fitz-Hugh-Curtis syndrome, 13:216 composition of, SA93:# 124 Fatigue Chlamydia and, 12:319(abs) elemental, SA93:#99 in Addison disease, 13:435 Fixation newborn, 13:88 infant, special 12:55 in congestive heart failure, 14:361 Flail chest, 14:237 tube feedings, composition of, Fatty acids Flashbacks, 14:466 SA93:#1 57 essential, SA93:#1 24 Flatfoot, 14:50(abs), 395 Fracture, 13:429 preterm, 14:123 Fluid, 14:70 basilar skull, SA92:#55 Fears, 13:16 and electrolytes, 14:103 in child abuse, 14:215; Febrile seizures, 13:298 requirements, renal failure, SA92:#138; SA93:#217, #306 and epilepsy, 14:190(abs) SA92:#113 in diseases of bone, 14:215 Feeding resuscitation, SA92:#27, #93 in osteogenesis imperfecta, 14:215 problems, 13:33 Flunisolide, 13:323 in young children, 14:281 technique, 13:453 Folic acid, SA93:#1 92 occult, 14:281 Femoral anteversion, 14:395; Food stress, limping and, 12:268 SA93:#1 18 allergy, 14:265; SA93:#69 toddler’s, 14:281 Fetal cow milk, SA92:#309 Free erythrocyte protoporphyrin, alcohol syndrome, 12:282; 13:364 hypersensitivity, 13:387 13 :461 (point-counterpoint), 12:375, Forced expiratory volume, 13:403 Frontal sinus fracture, 14:389 380 Forefoot adduction, 14:395 Functional abdominal pain, 14:313 anomalies, causes of, SA92:#1 06 Foreign body, 14:411; SA92:#47, Fungal infections, in heart monitoring, 13:262 #141 immunocompromised, SA93:#34 lead exposure, 13:461 aspiration, SA93:#296 Furazolidone, giardiasis, 14:284 toxins, 13:364 esophageal, SA93:#264 Fussy infants, 13:16 Fetus, drug effects, 12:282

G

G-6-PD deficiency, 14:191 Gastroenteritis Gaucher disease, SA92:# 123 Gait disturbance, 13:113 acute, documentation of, 12:372 Genetics, 13: 138, 197(abs) Galactosemia, 14:436 bloody, SA93:#1 99 counseling, SA92:#40 characteristics of, SA93:#98 Gastroesophageal reflux, Genital ophthamalogic findings in, 13:117(abs), 174; 14:155 anatomy, 13:443 SA92:#21 3 clinical findings, SA93:#307 development of hypospadias, Gallium scan, osteomyelitis, 12:292 cystic fibrosis and infant, SA93:#1 52 Gallstones, 14:155 12:371(abs) examination, 13:272(abs) Gamma globulin pH monitoring in, 12:383(abs) ulcers, 14:180 subclasses, 14:291 Gastrointestinal bleeding warts, 14:180 therapy, 14:226 lower, 12:85 Gentamicin, 14:11 Gardnerella, 13:443 upper, 12:107 Gestational age, 13:262 vaginalis, 14:141, 180 Gastrointestinal tract, preterm infant, Giardia infection, 13:283 Gastric lavage, 14:411 SA93:#242 diagnosis, SA92:#44 Gastritis, 14:352; SA93:#90 Gastroschisis, 13:50 treatment of, SA92:#44

506 Pediatrics in Review VoL 14 No. 12 December 1993 I #{149}- . : Giardia lamblia, 14:284 Gonadarche, 14:336(abs) charts, 14:492 Giardiasis, 14:284 Gonococcal constitutional, growth hormone Gifted child, 14:4 infections, 14:180 and short stature, 12:355 Glaucoma, in infants, SA93:#66 ophthalmitis, 14:423 cystic fibrosis, 13:73(abs) Glomerulonephritis Gonorrhea, 13:216, 443 deficiency, 13:453 acute, SA93:#241 cervicitis, SA93:#247 development and, 13:88 laboratory findings, SA92:#115 pharyngitis, SA93:#1 73 failure, 13:399(abs) Glucose, 14:238 treatment of, SA93:#248 growth hormone for, 12:355 polymers, low birth weight, urethritis, SA92:#90 perianal disease, 14:475 14:123 Gower sign, 13:391 hormone, 14:337 Gluten-free diet, celiac disease and, Graft-versus-host reaction, bone sports, 14:424 12:325 marrow transplantation, 12:364 therapy, SA92:#220 Glycogen storage disease, Granulocytes, transfusions, neonates, treatment of short stature, SA92:#1 23 12:298 12:355 Glycogen stores, newborn, 13:262 Graves disease, 14:481; SA93:#61 Guillain-Barr#{233} syndrome, 13:113 Glycosylated hemoglobin, Gray baby syndrome, 13:413 characteristics of, SA93:#1 37 SA92:#234 Grieving, SA92:#205; SA93:#1 11 mortality in, SA92:#179 Goiter, 14:481 Griseofulvin, 13:152 treatment of, SA93:#237 Golbert disease, 14:436 Group B streptococcal infection, Gynecomastia, 13:371 Gonadal dysgenesis, 13:43; 13:435 pubertal and psychosocial SA92:#24 Growth, 13:396(abs) development, 12:249

H

Haemophilus inJ7uenzae, 13:283; impairment, 14:320; SA92:#272 normal values, newborn, 14:11, 320 meningitis, 13: 1 12(abs) SA92:#1 65 bacteremia, 14:366(abs) loss, sensorineural, SA92:#1 26 Hematogenesis, spread, laboratory testing, SA92:#161 Heart osteomyelitis, 12:292 meningitis, 13:1 12(abs) arrhythmia, SA93:#20, #105 Hematoma, 14:424 rifampin, i3:354(abs) surgical treatment, 12:93(abs) epidural, SA93:#145, #189 Hair loss, SA93:#102 block, neonatal systemic lupus nasal septum, 13:275(abs) Half-life, drugs, 13:413 erythematosus, 14:194 Hematuria, 14:30 Hallucinogens, 14:466 disease, 14:488(abs) following trauma, SA92:#154 Haloperidol, 13:37(abs) congenital, 13: 1 18(abs), microscopic, SA93:#58 Hand-foot-mouth disease, 197(abs) Hemihypertrophy, abdominal masses, SA92:#1 97 feeding in, SA93:#315 12:196 Handicapping conditions, failure Hemoglobin dissociation, SA92:#30 SA92:#205 congenital, 13: 1 18(abs) Hemoglobinopathies, congenital, Handwriting, dyslexia, 13:231 congestive, 13:33 12:47 Hay fever, 13:323 murmur, innocent, SA93:#19 Hemolysins, 13:469 Head Heat Hemolysis, 14:218 banging, 13:16 exhaustion, SA92:#4 due to G-6-PD deficiency, 14:191 circumference, SA92:#21 9 loss, newborn, 13:262 in newborn, 14:191 injury, 14:286(abs) stroke, 14:424; SA92:#4 Hemolytic anemia, 13:469 children and adolescents, Height penicillin, 14: 152(abs) 12:9(abs) adult calculation, SA92:#302 Hemolytic uremic syndrome, 14:218 intracranial trauma, 12:179(abs) prediction of, SA92:#294 characteristics of, SA93:#95 tilt, and torticollis, 14:433 velocity, SA92:#294 Hemophilia, 13:138, 163, 183, 334 trauma, SA93:#145 Helicobacter pylon treatment and risks, 12:275 Headache gastritis, SA92:#223 treatment of, SA93:#8 and viral illness, SA92:#14 peptic ulcer disease, children, Hemoptysis, SA92:# 105 and migraine, SA92:#148 12:15 Hemorrhagic disease diagnostic tests, 13:248 Hemarthrosis, hemophilia and, of the newborn, 13: 163, 185, 262; treatment of, SA92:#39 12:275 14:191 Health care, preschool, high-risk, Hemachromatosis, 13:55; 14:436 preterm, 14:123 12:181 Hemangiomas, 13:371 Hemothorax, 14:237 Health supervision, evaluation by Hematemesis, 14:352 Hemotympanum, 14:320, 389 pediatrician, 12:11, 291 upper gastrointestinal bleeding, Henoch-Schoenlein purpura, 13:130; Hearing 12: 107 SA93:#75 assessment, SA93:#31 0 Hematocrit Hepatitis, 13:203, 245, 283; 14:436 disorders, 14:43 newborn, 13:262 chronic active, 13:203 cytomegalovirus, 14:436

Pediatrics in Review VoL 14 No. 12 December 1993 507 I

HIV, 14:371 Human diploid cell culture vaccine, Hyperleukocytosis, leukemia and, maternal, 13:262 rabies, 14:280 12:313 neonatal, SA93:#57 Human immunodeficiency virus Hyperlipoproteinemia, SA92:#1 60 transfusion-caused, 13:203 (HIV), 14:371; SA92:#80; Hypernatremia, 14:103; SA93:#268 Hepatitis A, epidemiology of, SA93:#1 0 Hyperphosphatasia, mental SA93:#1 44 exposure, evaluation by retardation and, 12: 126(abs) Hepatitis B pediatrician, 12:11, 291 Hypersensitivity chronic active, SA92:#228 infection, 13:443 penicillin, 14: 152(abs) occupational exposure, spinal cord, 14:364 treatment, 13:387 SA92:#1 24 Human milk Hypersplenism, 13:55 prophylaxis in exposed newborn, composition of, SA93:# 182 Hypertension, 13:130; 14:169 SA92:#77 drugs, 13:413 and steroid use, SA93:#40 vaccination, hemophilia and, preterm, 14:123 in children, SA93:#72 12:275 Human papillomavirus, 14:180 in neurofibromatosis, 14:433 Hepatocellular carcinoma, 14:436 Human parvovirus B19 infection, pulmonary, 14:431(abs) Hepatoma, 13:203, 245; 14:436 aplastic crisis, 12:142 treatment of, SA93:#202 Hepatomegaly, SA92:#228 Hyaline membrane disease, surfactant Wilms tumor, 12:196 Hepatosplenomegaly, SA92:#1 64 replacement therapy, 12:261 Hyperthyroidism Hereditary angioneurotic edema, Hydrocarbons, 14:411 and tachycardia, SA92:#78 13:387 Hydrocephalus, 13:293(abs), 295; laboratory evaluation of, Hernia 14:11 SA93:#61 diaphragmatic, 14:431(abs); diagnosis of, SA93:#41 Hypervitaminosis, 13:185 SA93:#228 myelomeningocele, SA92:#50 Hyphemia, 13:422 hiatal, 14:155 secondary to brain stem tumors, Hypoalbuminemia, 14:30 inguinal, SA93:#46 12: 190(abs) cystic fibrosis and, 12:384(abs) Heroin, abuse of, SA92:#198 Hydrogen breath test, 13:437(abs) effect on serum theophylline Herpes simplex Hydrometrocolpos, 13: 129(abs) levels, SA93:#219 encephalitis, SA92:#1 22; Hydronephrosis, 13:25 Hypocalcemia, 13:197(abs); 14:123 SA93:#272 Hydrops fetalis, 13:236(abs); signs and symptoms of, SA93:#91 genitalis, 13:443 SA92:#274 Hypochloremia, in pyloric stenosis, virus, 13:107; 14:141, 251 Hydroxazine, urticaria, 13:387 SA93:#226 sexually transmitted diseases, Hymen, injuries, 13:443 Hypocomplementemia, in nephritis, 14:180 Hymenoptera, 14:246(abs) SA93:#241 virus-6, roseola, 12:255(abs) Hyperactivity, 14:455 Hypoglycemia, 14:238(abs) zoster, 13:107; SA93:#234 children and adolescents, 12:218 evaluation of, SA93:#50 Hip Hyperbilirubinemia, 14:436, 493 neonatal, 13:262; SA92:#227 congenital dislocation, SA93:#31 and hemolytic disease, SA92:#22 preterm, 14:123 use of mannequins in training, and sepsis, SA92:#41 Hypokalemia, 14:70 13 :244 conjugated, SA92:#41 effect of acidosis on, SA92:# 145 dysplasia, 13:262 hepatitis, 13:203, 245 electrocardiogram in, SA92:#1 0 limb pain, 12:39 in hemolytic anemia, 13:469 treatment of, SA93:#96 pain in ankylosing spondylitis, neonate, 12:259 (commentary), Hyponatremia, 14:70, 103, 269 14:117 13:113 and adrenal insufficiency, Hirschsprung disease, 13:25, 50; documentation of, 12:259 SA92:#62 SA92:#21 2; SA93:#1 32 due to G-6-PD deficiency, and anasarca, SA93:#1 27 Histocytosis X, 13:371 ; SA93:#206 14: 191 factitious, SA92:#207 HLA antigens, 14:117 newborn, 13:262 total sodium in, SA93:#127, Hodgkin lymphoma, SA93:#38 physiologic in term vs preterm #190 and non-Hodgkin lymphoma, infants, SA93:#77 Hypoplasia, pulmonary, 14:431(abs) 12: 171 unconjugated, SA92:#22; Hypoproteinemia, in cystic fibrosis, Home monitors, 14:5 1 SA93:#1 98 13:183 Homosexuality, 14:401 Hypercapnia Hypospadias, 14:494(abs) Homovanillic acid, abdominal manifestations of, SA93:#5 Hypothermia, SA92:#244 masses, 12:196 symptoms of, SA93:#5 drowning, 14:148 Hospitalization Hypercholesterolemia, 14:30 treatment of, SA92:#249 necessity (commentary), 12:195 characteristics of, SA92:#1 60 Hypothyroidism preparation, 13: 126(abs) risk factors for, SA93:#205 congenital, SA92:#86 psychologic preparation of Hypercyanotic spell, SA92:#1 17 laboratory evaluation of, children, 12:332(abs) Hyperinsulinism, SA92:#1 3 SA93:#209 Hostility, 14:380 Hyperkalemia, SA93:#20 Hypotonia, 14:117; SA92:#108 treatment of, SA92:#280; Hypoxic-ischemic encephalopathy, in SA93:#1 96 newborn, SA93:#1 04, #303

508 Pediatrics in Review VoL 14 No. 12 December 1993 I - ; : I

Ibuprofen, overdose, 12:331(abs) Immunoglobulin, 14:291 Inhalers, use of, SA93:#1 13, #296 Ichthyosis vulgaris, management of, disorders, 14:226 Inherited disorders of central nervous SA93:#1 65 immunodeficiency and, system, 13:157 Idiopathic thrombocytopenic purpura, SA93:#200 Injury, 13:429; 14:424 13:163; SA93:#27 intravenous, neonates, 12:298 athletic, SA93:#65 Iliopsoas hemorrhage, hemophilia subclasses of, SA93:#232 prevention, 13:276(abs) and, 12:275 Imperforate hymen, SA92:#21 , #52 recurrent, evaluation by Imaging, 14:345 Impetigo, etiology of, SA92:#271 pediatrician, 12:11, 291 Imipramine, SA92:#268 Inappropriate antidiuretic hormone, spinal cord, SA93:#1 16 Immediate hypersensitivity, 13:387 14: 1 1 ; SA92:#38; SA93:#238 Insect Immune dysfunction, 14:345 Inattention, 14:455 stings, 14:246(abs) Immune globulin, 13:143(abs) Indexofsuspicion, 13:33, 113, 157, venoms, 13:387 administration of, SA92:#292 269, 295, 391, 469; 14:117, 155, Insomnia, in cocaine abuse, 14:361 anaphylaxis to, SA92:#3; 191, 215, 281, 361, 433 Insulin, SA93:#227 SA93:#252 Infancy, 13:16 Intelligence tests, 14:4 E, penicillin reaction, 14:152(abs) Infant International pediatrics, 14:95 side effects of, SA92:#3; formula, composition of, Interview, drug abuse, 13:314 SA93:#252 SA93:#1 24 Intestinal obstruction, 13:130; varicella-zoster, indications for, newborn and premature, 13:262 SA92:#1 19 SA93:#1 01 preterm-see Premature infant management of, SA92:#59 Immunity, specific, SA93:#214 walkers, 14:286(abs) In-toeing, SA93:#1 18 Immunizations, 13:98 Infantile spasms Intoxication, 14:411 diphtheria, SA92:#54; SA93:#201 associated conditions, SA92:#291 Intracellular fluid, 14:70 HIV, 14:371 natural history of, SA93:#4, #106 Intracranial hemorrhage, hemophilia in adolescence, SA93:#52 treatment of, SA92:#275 and, 12:275 in immunodeficient, SA92:#57, Infection Intracranial herniation, SA92:#1 35 #277 adenoviral, SA92:# 131 Intracranial pressure in preterm infant, SA92:#204 anaerobic, SA92:#226 increased incomplete records, evaluation by chlamydial, 13:216 diagnosis, SA92:#48; pediatrician, 12:11, 291 congenital, SA92:#263 SA93:#41, #63 influenza, SA93:#68 fungus, 13:152 in infants, SA92:#101 measles, SA92:#1 10 gingivitis, SA92:#226 Intractable diarrhea, 14:312(abs) pneumococcal, SA93:#276 group B streptococcal, 13:143(abs) Intraluminal feeding, 14:312(abs) pertussis, SA93:#201, #221 immunodeficiency, 14:226 Intrauterine growth retardation, school entry, 13:98 in immunocompromised, 13:334; SA93:#104 simultaneous administration, SA93:#34 Intravenous 12:83(abs) parvoviral, SA92:#274 access, 14:237 tetanus, SA92:#54; SA93:#125 streptococcal, SA92:#276; immunoglobulin, 14:371 Immunocompromised, infections in SA93:#1 67 Intubation, use of mannequins in and human immunodeficiency urinary tract, SA92:#215 training, 13:244 virus, varicella exposure, with leukemia, 12:313 Intussusception, 13:50, 391 ; 14:302 SA93:#1 00 Infectious diseases, 13:283 Ipecac, 14:411 Immunodeficiency, 14:226 Infectious mononucleosis, IQ scores, 13:231 bone marrow transplantation, SA93:#1 47 Iridocyclitis, in ankylosing 12:364 documentation of, 12:134 spondylitis, 14:117 complications of, SA93:#273 neurologic complications, Iron, 13:273; 14:411 disorders, 14:291 SA92:#63 deficiency, SA92:#23; 14:123 evaluation of, SA93:#200 Infertility, 13:216 anemia, 13:461 immunizations and, SA92:#57, Inflammatory bowel disease, 14:475 fortification, 13:36(abs) #277 Influenza requirements, SA92:#34, #142 screening tests, SA93:#200 treatment of, SA93:# 133 Irradiation, cranial, leukemia and, toxoplasmosis and, 12:227 vaccine, SA93:#68 12:313 treatment of, SA92:#292; Influenza A, SA93:#1 33 Irritability, in cocaine abuse, 14:361 SA93:#34 Ingestion Irritable bowel syndrome, vaccination, 13:98 caustic, SA92:#46, #114 13:397(abs); 14:313 Immunofluorescent test, Chlamydia, phenobarbitol, SA93:#1 12 Isoniazid, 13:343 14:180 tricyclic antidepressants, SA92:#268

Pediatrics in Review VoL 14 No. 12 December 1993 509 I I J

Jaundice-see Hyperbilirubinemia Jimson weed, 14:466 Juvenile delinquency, 12:218

K

Kallman syndrome, 13:43 Ketoconazole, 13:152 Klinefelter syndrome, 13:435 Kawasaki disease, SA93:#185 Kidney Klumpke paralysis, 13:77(abs) laboratory findings, SA92:#98 disease, 13:130 Knee, 13:429 Kerion, 13:152; SA92:#305 enlargement, 13:25 pain, in bone tumor, 13:469 Kernicterus, 14:191 stones, 11:21 Kwashiorkor, 14:95

L

Lacerations, 13:257; SA93:#36 Left upper quadrant mass, 13:25 Listena monocytogenes, 13:277(abs) Lactose deficiency, 13:437(abs) Legg-Calve-Perthes disease, limping Listeriosis, 13:277(abs); 14:262 Lactose and, 12:268 Lithium, 13:364 formulas and, SA92:#269 Length growth, 13:88 effects on fetus, 12:282 intolerance, 13:397(abs), 437(abs); Lens, 13:422 Liver disease, 14:436, 493(abs); 14:313; SA92:#74 Lethargy, 14:117 SA93:#1 40 Lange-Jervell-Neilsen syndrome, Leukemia Long QT interval, 13:469 14:43 bone marrow transplantation, Lorazepam, seizure management, Langerhans cell histiocytosis, 12:364 12:31(abs) SA93:#206 complications, 12:313 Low birth weight, 14:238(abs) Language, 14:43 lessons learned from children prevention, 13:64 delay, 13:231 (commentary), 12:6 LSD, 14:466 development, 14:4 limping and, 12:268 Lumbar puncture, SA92:#245 disorder, 14:455 pediatrician and (commentary), use of mannequins in training, skills, 14:151(abs) 12:5 13:244 Laryngoscopy, SA93:#246 Leukocyte, transfusions, neonates, Lupus, 14:194 Latex particle agglutination, 14:11 12:298 Lying, children and adolescents, test, SA93:#85 Leukokoria, 13:7 12:218 Laurence-Moon-Biedle syndrome, Lid lacerations, 13:422 Lyme disease 14:337 Limb pain causative agent, SA92:#94 Laxatives, 14:447 childhood, 12:39 limb pain, childhood, 12:39 Lead, 13:461 osteosarcoma and, 12:333 limping and, 12:268 poisoning Limb-girdle muscular dystrophy, Lymph nodes, 13:371 fetal, 12:14(abs) 13:391 Lymphadenitis management, 13:461 Limp atypical mycobacterial, Learning examination of children, 12:268 14:263(abs) disabilities, 14: 15 1 (abs), 213(abs), osteosarcoma and, 12:333 cervical, 14:263(abs) 214(abs) Lipid storage disease, SA92:#1 23 Lymphadenopathy, 13:371 evaluation of, SA93:#308 Lipidosis, SA92:# 164 cervical, SA93:#37 treatment of, SA93:#262 Lipids, in formula, SA93:#124 Lymphoid interstitial pneumonitis, disorders, 14:455 Lipomas, 13:371 14:371 effect of medications on, Lisch nodules, in neurofibromatosis, Lymphoma, non-Hodgkin, 12:171 SA93:#301 14:433 problems, 13:312

M

Macrocephaly, SA93:#1 8 Mallory-Weiss syndrome, diagnosis Marfan syndrome Magnetic resonance imaging, and management, 12:107 cardiovascular involvement in, osteomyelitis, 12:292 Malnutrition, 13:453; 14:95, 492 12:46(abs) Malabsorption, 13: 185, 437(abs); Malrotation of gut, 14:302 characteristics of, SA93:#21 6 14:475 Management, learning disability, pneumothorax, 13:398(abs) celiac disease and, 12:325 14:213(abs) Marijuana Maladjustment, 14:447 Mania, 14:380 abuse, 13:314 Malaria, 14:95 Mannequins, 13:244 effects of, SA93:#1 28 Malignancy, 13:371 Mantoux test, 13:343 Mastoiditis, 14:320; SA92:#1 50, pediatrician and (commentary), Marasmus, 14:95 #242; SA93:#284 12:5 Masturbation, 14:401

510 Pediatrics in Review VoL 14 No. 12 December 1993 I . Maternal drugs, 13:262 bacterial, SA92:#1 27, #287, human Maturation, Tanner stages, #301 jaundice (point-counterpoint), SA92:#201 causes, 14:155 12:67 Measles complications, 13: 1 12(abs) vitamin D, 13:185 complications of, SA93:#240 Haemophilus influenzae and, intolerance, 13:437(abs) in immunocompromised, SA92:#1 61 Minerals, 14:123 SA92:#1 78 laboratory evaluation of, excretion, low birth weight infants,

immunization, SA92:#1 10 SA92:#1 61 , #287; SA93:#85 12: 101(abs) HIV, 14:371 neonatal, SA92:#301 Mitral insufficiency, 14:272(abs) prophylaxis for, SA92:#1 78 partially treated, management of, Molluscum contagiosum, transmission of, SA92:#1 10 SA92:#287 management of, SA93:#22 Measles, mumps, rubella vaccine, prophylaxis, 13:370(abs) Mongolian spots, 14:215 14:245(abs) Meningococcal infection, 13:283, Monitoring, 14:83 Meckel diverticulum, 13:50; 14:302 354(abs) Moraxella catarrhalis, 14:320 Meconium, 13:262 Meningococcemia, chronic, 13:269 Mothballs, 14:411 aspiration, radiologic findings, Menometrorrhagia, causes of, Mother-infant interaction, 13:453 SA92:#66 SA93:#247 Motor development, 13:88 ileus, SA93:#175 Mental retardation, 14:151(abs), 455 Mouth breathing, 13:323 suction, 13:237(abs) early intervention by pediatrician, Movement disorders, drug-induced, Median femoral torsion, SA93:#1 18 12:305 SA92:#237 Medical record review in infancy, SA93:#286 Mucoceles, 13:371 asthma, 13:203 intelligence quotient, SA93:#286, Mucosal ulceration, clinical disorders chronic abdominal pain, 14:67 #313 of neutropenia, 12:208 head injury, 14:299 Mescaline, 14:466 Mumps otitis media, 13:355 Metabolic disorders complications of, SA93:#21 0 seizures, 13:75 evaluation of, SA93:#50, #195 pancreatitis and, SA93:#21 0 Medical records of central nervous system, 13:157 Munchausen syndrome by proxy, acute gastroenteritis, 12:374 Metabolism, inborn errors of, syrup of ipecac, 12: 180(abs)

acute pharyngitis, 12:134 SA93:#50, #1 71 , #195 Muscle commentaries, 12:131, 132, 259, Metatarsus adductus, 14:395 disease, 12:73 372 Metatarsus varus, 14:395 weakness, 12:117 documentation of hospital care in Methamphetamine, 13:330; Muscular dystrophy, 13: 1 16(abs), the office, 12:259 14: 101(point-counterpoint) 391 indirect neonatal Methanol, 13:273; 14:411 Duchenne, SA93:#1 74 hyperbilirubinemia, 12:259 Methemoglobin, 14:411 sleep disorders in, SA93:#1 74 review of, 12:131 Methemoglobinemia, acquired, Mushrooms, 14:411 in Program for Renewal of 12:72(abs) Multiple endocrine neoplasia (MEN), Certification in Pediatrics, Methylmalonic acidemia, 14:481 13: 131 SA92:#1 56 Multiple mucosal neuromas, 14:481 telephone contacts in, 12:372 Methylphenidate, SA93:#262 Myasthenia gravis, 13:38(abs); Medication side effects, SA92:#49 14:361 administration to children, 13:195 Metoclopramide, 13: 1 17(abs) children, 12:73 palatability, 13:195 gastroesophageal reflux, Mycobacteria Medium chain triglycerides, 14:123 13: 198(abs) atypical, SA93:#1 55 Medullary thyroid carcinoma, 14:481 Metronidazole, giardiasis, 14:284 nontuberculous, 14:263(abs) Melanomas, 13:371 Miconazole, 13:152 Mycobacterial lymphadenitis, Membranoproliferative Microcephaly, SA92:#21 9 14:263(abs) glomerulonephritis, 14:30 Microcolon, SA93:#1 75 Mycoplasma, 14:251 Membranous glomerulonephritis, Middle ear effusion, 13:355 Myelomeningocele, 13: 1 16(abs), 14:30 Migraine, adolescents, 12:302(abs) 293(abs) Menarche, SA92:#21 0 Milk Myelopathy, 14:364 pubertal and psychosocial cow 13:36(abs) Myopathy development, 12:249 enteropathy, celiac disease, children, 12:73 Meningitis, 14:11, 251 12:325 juvenile, 12:117 aseptic, 14:155 feeding, 6-12 months, 12:187 Myringotomy, 13:355; 14:320

N

N-acetylcysteine, 14:411 Narcotic Nasal Nafcillin, bone infections, agents, SA92:#39 eosinophils, 13:323 SA92:#1 96 overdose, 13:273 septum, hematoma, 13:275(abs) Naloxone, 13:273 sinus fracture, 14:389

Pediatrics in Review VoL 14 No. 12 December 1993 511 I I

smears, eosinophils, SA93:#300 Neural tube, defects, 13:334 shock, 13:358(abs) stuffiness in infants, SA93:#295 Neuroblastoma, 13:25; 14:169 Niacin, overdose, 14:433 Nasopharyngeal suction, 13:237 (abs) identification of, 12:196 Nicotine, 14:275 Natural killer-cell deficiency, 14:226 pediatrician and (commentary), Niemann-Pick disease, SA92:#164 Near-miss apnea, 14:83 12:5 Night waking, 13:16 Near-miss SIDS, 14:5 1 Neurodiagnostic tests, 13:248 Nitrofurantoin, pulmonary reactions, Necrotizing enterocolitis, SA92:#1 21 Neurofibroma, 13:371 12:23(abs) Neglect, 13:453 Neurofibromatosis, 12: 166; 14:433 Nodule, 14:481 Neisseria meningitidis, 13:370(abs); caf#{233}-au-lait spots in, SA93:#283 Nonstress test, SA92:#28 14:11 characteristics of, SA93:#32, Nontuberculous Neonatal #114, #283 adenitis, 13:371 behavioral assessment scale, 13:88 evaluation of, SA93:#32 mycobacteria, 14:263(abs) drug withdrawal, 13:314 Neurogenic bowel, SA92:#262 Norepinephrine, 14:489 eye prophylaxis, 14:423 Neurologic development, 13:88 Nose breathing, in infants, left colon syndrome, SA92:#56 Neuromuscular disease, children, SA93:#295 pneumonia, 13:435 12:73 Nosocomial spread, 13:283 sepsis, 13:435 Neuropathy, SA93:#26 Nuclear war, fears about, systemic lupus erythematosus, Neutropenia, 14:226 SA93:#271 14:194 clinical disorders, 12:208 Nurse home-visiting, 13:64 withdrawal, 14:466 idiopathic, SA93:#1 64 Nurse maid elbow, SA92:#36 Neonatal disorders leukemia and, 12:313 Nutrition, 14:123 bacteremia, therapy of, SA93:#23 neonates, 12:298 and iron deficiency, SA92:# 142 left colon syndrome, SA92:#56 transient, SA92:#72 cow milk feeding 6-12 months, meningitis, SA93:#23 Nevi, 13:371 12: 187 Neonate Newborn, 13: 163, 237(abs); 14:262 enteral, SA92:#253, #279 blood loss, 12:47 cardiopulmonary resuscitation, in sports, 14:424 death (commentary), 12:163 12:136 parenteral, 14:123; SA92:#253 Nephropathy, IgA, SA92:#97 chronic hepatitis, 13:203, 245 total parenteral, 14:475 Nephrotic syndrome, 14:30, 70, 226 infant development, 13:88 Nutritional status, 14:492 prognosis, 12: 132(abs) seizures, 13:305 0

Obesity, 13:144, 396(abs); 14:337 Oral ulcers, 14:475 Otitis externa causes of, uncommon, SA93:#1 69 Orchitis, SA93:#67 microbiology of, SA92:#31 morbid, SA92:#12 Organic phosphates, 13:273 treatment of, SA93:#97 Obstruction Organophosphates, SA92:#1 74 Otitis media, 13:199(abs), 355; airway, SA93:#82, #183 poisons, 14:411 14:320 intestinal, SA92:#59, #285 Orthostatic proteinuria, 14:30 acute renal, SA92:#129 Osgood-Schlatter disease, 13:429; age distribution, SA93:#1 17 uteropelvic junction, SA92:#1 29 SA92:#1 25 manifestations of, SA93:#64 Obstructive apnea, 14:51 limping and, 12:268 microbiology of, SA92:#238 Obstructive lung disease, 13:473(abs) Osmolality, serum, calculation of, treatment of, SA92:#1 80; Occult bacteremia, 14:366(abs) SA92:#21 4 SA93:#211, #220, #284 prevalence of, SA93:#254 Osmolargap, 13:273; 14:411 and cholesteatoma, SA93:#21 1 Ocular weakness, in myasthenia Osmolarity, 14:70 and conjunctivitis, SA92:#26 gravis, 14:361 Osteochrondritis dissecans, 13:429 chronic Omphalocele, 13:50 Osteochondromas, limping and, associated conditions, Oncogenes, cancer and the 12:268 SA92:#1 68 pediatrician (commentary), 12:5 Osteogenesis imperfecta, 14:215 microbiology, SA92:#238 Ophthalmologic abnormalities, Osteogenic sarcoma, 13:469 complications of, SA92:#1 50, SA92:#21 3 limping and, 12:268 #242, #287; SA93:#284 Opioids, pain management, 12:237 Osteomyelitis infants, microbiology of, Oppositional defiant disorder, diagnosis, 12:292 SA92:#293 children and adolescents, 12:218 evaluation, 12:333 perilymphatic fistulas and, Optic glioma, in neurofibromatosis, limping and, 12:268 12:35 1(abs) 14:433 microbiology of, SA92: #118, recurrent, 13:23 Oral contraceptives, 13:83 #202 Otitis with effusion, 14:43 risks of, SA93:#293 treatment of, SA92:#1 96 Otorrhea, bloody, etiology of, Oral rehydration, 14:95 Osteosarcoma, 13:469 SA93:#1 09 solutions, composition of, evaluation, 12:333 Otoscopy, 14:320 SA93:#291 Otalgia, 13:355; SA93:#319 Outcomes, 14:208

512 Pediatrics in Review VoL 14 No. 12 December 1993 . ... . F Oximetry, pulse, SA92:#30

Ovary, torsion of, 13:183 Oxygen saturation, newborn, Overdose, opiate, SA92:#69 Oxygen desaturation, 13:1 16(abs) SA93:#256 Oxygenation, 13:473(abs) P

Pain, 13:429 pharmaceutical manufacturer and medical record documentation, abdominal, 14:67, 302 (commentary), 12:323 12:134 chest, SA92:#2 response to neonatal death streptococcal chronic, 14: 167(abs) (commentary), 12:163 antigen detection test for, in knee, referred from hip, 13:157 Peer factors, drug abuse, 13:314 12: 13(abs) management of, 12:237; Pellagra, 13:185 characteristics of, SA92:#1 51 SA93:#43 Pelvic examination, 13:43 treatment of, SA92:#102 postoperative, management in Pelvic inflammatory disease, 13:216; Pharyngoconjunctival fever, children, 12:237 14:180 SA92:#1 31 recurrent abdominal, SA92:#1 44 contraception, 13:216 Phencyclidine, 13:273; 14:466 referred, SA93:#319 Penicillin Phenobarbital, 13:298, 413 Palate, submucous cleft, 14:191 activity of, SA93:#244 drug interactions, SA93:#275 Pancreatic allergy overdose, SA93:#1 12 enzymes, SA92:#222 alternatives, SA93:#1 Phenylketonuria, SA92:#241 exocrine, SA92:#76 testing, SA93:#42 Phenytoin, 13:413; SA93:#194 insufficiency reactions, 14: 152(abs) Pheochromocytoma, 14:169 causes of, SA93:#44 uses of, SA92:#102; SA93:#244 Physical abuse, cutaneous signs of, in infants, SA93:#203 Pentamidine, HIV, 14:371 SA93:#288 in cystic fibrosis, 13:183 Peptic ulcer, 14:313 Physical growth, 13:88 Pancreatitis, 13:32(abs); 14:302 causes in children, 12:15 Pickwickian syndrome, 14:337 laboratory evaluation of, upper gastrointestinal bleeding, Pierre Robin, SA93:#1 78 SA93:#220 pediatric patient, 12:107 Pilomatrixomas, 13:371 mumps and, SA93:#210 Percentile charts, 13:396(abs) Pilonidal dimples, 13:262 Panic disorder, 13:381 Periactin, urticaria, 13:387 Pimozide, 13:37(abs) Papanicolaou smear, SA92:#1 77 Pericarditis, 14: 153(abs); Pin worms, 14:141 Papular acrodermatitis, 13:203 SA93:#270 PKU-see Phenylketonuria Paracentesis, abdominal trauma, Perilymph fistulas, infants and Plano valgus, 14:50(abs), 395 I 3:238(abs) children, 12:351(abs) Plasma volume, 14:70 Paraquat, 14:411 Perinatal infections, 14:25 1 Platelet count, in bruising, 14:215 Parasitology, toxoplasmosis and, Perineal contact dermatitis, 14:240 Pneumatoceles, SA93:#267 12:227 Periodic breathing, 13:262; 14:51; Pneumatoscopy, 13:355 Parasympathetic nervous system, SA93:#62 Pneumococcal vaccine, SA93:#276 14:489 Periodontal disease, SA92:#226 Pneumococcus bacteremia, Parathyroid absence, 13: 197 (abs) Periorbital swelling, 14:345 14:366(abs) Parent-child centers, 13:64 Perirectal abscess, leukemia and, Pneu,nocystis cannii Parenteral 12:313 infections, 14:226 alimentation, 14: 103; SA92:#1 04 Pertussis, 13:283, 438(abs); pneumonia, 14:371 nutrition, 14:123, 312(abs) SA93:#221 prophylaxis, SA93:#1 0 Parenting, SA93:#86 vaccine Pneumomediastinum, 13:398(abs) Parotitis, SA92:# 183 contraindications, SA93:#201 Pneumonia, 14:25 1 Paroxysmal dose, SA93:#201 bacterial, SA92:#75 crying, 13:16 Pesticide poisons, 14:411 causes, SA92:#273 supraventricular tachycardia, Petechiae, 13:269 complications of, SA93:#267 14:273 causes, 14:215 immunodeficiency, 14:226 Partial complex seizures, 13:305 Pets, 13:283 mycoplasma, SA92:#303; Partial thromboplastin time, 13:163 Phagocytic dysfunction, 14:226 SA93:#279 Parvovirus, 13:236(abs) Pharmaceutical manufacturer, presentation of, SA92:# 191 Passive smoke, 14:444 pediatrician and (commentary), prophylaxis for, SA93:#10 Pasteurella infection, 13:394(abs) 12:323 radiologic findings, in newborn, Patella, 13:429 Pharmacokinetics, 13:413; SA93:#7 SA93:#1 07 subluxation, limping and, 12:268 Pharmacology, children, 13:413 recurrent, 14:371 Patellofemoral pain, 13:429 Pharyngitis, 14:25 1 staphylococcal, SA93:#267 PCP, 14:466 differential diagnosis, SA92:#1 51 Pneumothorax, 13:398(abs); 14:237; Peak expiratory flow rate, 13:403 gonococcal, SA93:#1 73 SA93:#278 Pediatrician laboratory evaluation of, Point-counterpoint, 12:35, 67, 379; inpatient care, 12:165 SA93:#1 67 13:36; 14:101, 324

Pediatrics in Review VoL 14 No. 12 December 1993 513 I :. . #{149}, “ #{149}: I Poison ivy, 14:240 alcohol consumption (point- Psoriasis vs atopic dermatitis, Poisoning, 13:273; 14:411; counterpoint), 12:375 SA92:#15, #297 SA92:#259; SA93:#49 ectopic, 13:216 Psychological carbon monoxide, 13:6(abs), 295 teenage, 14: 1 16(abs) assessment, 14:455 caustic substances, SA93:#6 Prenatal diagnosis, 13:138, 334 tests, 14:455 dermatitis, SA92:#247 DNA, 13:138 Psychosocial fetal, 12:14(abs) PREP, Pediatrics Review and adjustment, 13:224 organophosphate, SA92:#1 74 Education Program, pickles, pizza, development, 13:88 prevention of, SA93:#251 and (commentary), 13:3 Psychostimulant medications, 14:455 Polyarteritis nodosum, hepatitis, Preterm Ptosis, congenital vs acquired, 13:203, 245 definition, 13:262 SA93:#53 Polycystic kidney disease, infants, fluid therapy, 14:103 Puberty, SA92:#210; SA93:#246 SA93:#298 Primary care, 13:224 delayed, SA92:#210; SA93:#32 Polycystic ovary syndrome, 13:43; Proctitis, 14:180 boys, 13:5(abs) SA93:#94 Progressive systemic sclerosis, precocious, 14:336(abs) Polycythemia, 13:379 SA92:#231 psychosocial development and, neonatal, SA92:#227 Prolonged QT interval, 13:469 12:249 Polyhydramnios, 13:50 Prophylaxis for Tanner staging in, SA93:#87 Polymerase chain reaction, 13:138 dental procedures, SA92:#68 Public Law 142, developmental HIV, 14:38(abs) rifampin, 13:354(abs); SA92:#1 36 disabilities, early intervention, Polymyalgia rheumatica, 13:203 sexually transmitted diseases, 12:305 Polymyositis SA93:#1 30 Public Law 99-457, developmental children, 12:73 Propranolol, 13:413 disabilities, early intervention, juvenile, 12:117 Prostaglandins, 13:83 12:305 Polyps Protective equipment, sports, 14:424 Pulmonary nasal, SA93:#245, #287 Protein disease, exercise, 13:474(abs) rectal, SA93:#294 digestion, preterm, 14:123 edema, noncardiac, 14:163 Positive end-expiratory pressure intolerance, SA92:#309 function tests, 13:403; SA92:#243 (PEEP), SA92:#190 malnutrition, 14:95 Pulsus paradoxus, 13:403 Positron emission tomography, restriction, in renal disease, Puncture wounds, 13:257; SA93:#88 13 :248 SA93:#309 Pupillary response, infants, Posterior urethral valves, SA92:#306 Proteinuria, 14:30 SA92:#255 Poststreptococcal nephritis, exercise-induced, SA93:#1 31 Purpura, 13:130 laboratory findings, SA93:#241 transient, SA93:#131 causes, 14:215 Potassium Prothrombin time, 13:163 idiopathic thrombocytopenic, and acidosis, SA92:# 145 Pseudomembranous colitis 14:215 daily requirements, SA92:#260 laboratory evaluation of, Pyelonephritis, therapy of, Potassium iodide, 13:152 SA93:#78 SA93:#269 PPD tuberculin skin test, 14:263(abs) management of, SA93:#48 Pyloric stenosis, SA93:#226 Prader-Willi syndrome, 14:337; Pseudomonas, antibiotic therapy, Pyoderma gangrenosum, 14:475 SA93:#1 69 SA93:#257 Pyogenic granuloma, 13:371 Preauricular tags, 13:371 Pseudostrabismus, 13:7 Pyrantel pamoate, SA93:#1 15 Prepubertal children, 13: 15 1(abs) Pseudotumor cerebri, SA92:#1 94 Pyrazinamide, 13:343 Pregnancy, 13:43, 216 Psilocybin, 14:466 Pyrimethamine, toxoplasmosis and, 12:227 Q

Quality improvement, 14:208 QT interval, prolonged, 13:469

R

Rabies, 14:280(abs) penicillin, 14: 152(abs) Recurrent animal carriers of, SA93:#259 Reactive airways, 13:403 abdominal pain, 13:397(abs); Ranula, SA92:#67 Reading 14:313 Radial artery puncture, use of development, 13:231 infections, 14:291 mannequins in training, 13:244 disability, 13:231 pain, 14:167(abs) Radiography, osteomyelitis, 12:292 Receptors, autonomic, 14:489 respiratory infections, 14:226 Radionuclide, vesicoureteral reflux, Rectal bleeding, 14:352; SA93:#294 Reflex sympathetic dystrophy 13:279(abs) infants and children, 12:85 syndrome, children and Rash Rectal manometry, 14:447 adolescents, 12: 102(abs) in niacin overdose, 14:433

514 Pediatrics in Review Vol. 14 No. 12 December 1993 I . I I Reflux surfactant replacement therapy, infection, 14:371 gastroesophageal, 14:155; 12:261 Reye syndrome, SA92:#6; SA93:#307 disturbance, 13: 1 16(abs) SA93:#1 4 nephropathy, 13:279(abs) failure, SA92:#1 75 Rheumatic fever, 14:194, 272(abs) vesicoureteral, SA93:#31 1 infection, 14:345 Rhinitis, 13:323 Rehydration, oral, SA93:#291 syncytial virus, 14:134, 251 allergic, SA93:#300 gastroenteritis, 12:372 recurrent wheezing and, in cocaine abuse, 14:361 Renal 12:63(abs) Rhinovirus, 13:283 anomalies, SA93:# 142 transmission of, SA93:#263 Rhythm disturbances, cardiac, aplasia, SA92:#5 tract disease, lower, 13: 196(abs) 14:273 disease, hereditary, SA92:#43 Restriction fragment length Ribovarin therapy, 14:134 protein intake in, SA93:#309 polymorphisms, hemophilia and, Rickets, 13: 185; SA92:#290 failure, 13:130; 14:103, 218 12:275 preterm, 14:123 management of, SA92:#113; Resuscitation, newborn, 12:94(abs) Rickettsia, petechiae, 13:269 SA93: #196 Reticular agenesis, 14:226 Rifampin, 13:283, 343, 354(abs); systemic lupus erythematosus, Retinal detachment, 13:422 SA92:#1 36 14:194 Retinitis, HIV, 14:371 Ringworm, 13:152 tubular acidosis, 13:391; Retinoblastoma, 13:7 Risk factors, 13:64 SA93:#222 leukokoria in, SA92:#140 Rock music, 13:144 tumor, 13:25 Retinol, 13:185 Rocky Mountain spotted fever, vascular hypertension, 14:169 Retinopathy of prematurity, 13:269; SA92:#233 Repetitive movements, 13:16 12: 106(abs); SA92:#1 03; Roseola, herpes virus-6 and, Reproductive health, 14:180 SA93:#1 7 12:255(abs) Respiratory Retropharyngeal abscess, 14:19 Rotavirus, 13:283; SA93:#305 distress syndrome, SA92:#270 Retrovirus, SA92:#80 Rumination, 13:174

S

Salicylates, 14:411 intervention, 12:305 infant, 12:330(abs) and Reye syndrome, SA93:#14 illicit drug use, 12:207(abs) leukemia and, 12:313 chronic use of, SA92:#209 lead, 13:461 liver disease, 14:436 poisoning, 13:33 newborn, SA92:#213 newborns, 13:163 Salmonellosis, SA92:#29 preschoolers high-risk, 12:181 Sequestration, bronchopulmonary, Salpingitis, 13:216 vision problems (commentary), 13:4 SA92:#264 acute, 13:216 visual acuity test, SA92:#224 crisis, 13:33 Sandifer syndrome, 13:174 Scrotum, acutely painful, 13:295 Serum sickness Sarcomas, 13:371 Scurvy, 13:185 hepatitis, 13:203, 245 Scabies, SA92:#297 Seat belts, 14:244(abs) penicillin, 14: 152(abs) School Sebaceous cysts, 13:371 Serum osmolarity, 14:70 absenteeism, 12: 1 16(abs) Sedatives, 13:381 Sex chromatin anomalies, readiness, 14:4 Seizures, 13:75; SA93:#95 13: 1 19(abs) failure, 14:214(abs) afebrile, 13:305 Sexual abuse-see Abuse, sexual prevention, 13:64 and diarrhea, SA93:#95 Sexual behavior, in adolescents, health cardiac causes, 13:469 SA93:#1 35 management of asthma, 14:391 febrile, 13:298 Sexual maturation 13:43, 88 pediatrician in (commentary), infantile spasms, SA92:#291; Sexual orientation, SA92:# 199 12:69 SA93:#4, #106 Sexuality, 13:144; 14:180, 401 performance, 14:455 lorazepam, 12:31(abs) Sexually transmitted diseases, Scleroderma, SA92:#231 neonatal, SA92:# 163 13:216, 443; 14:141, 180; Scoliosis, 14:297 petit mal, SA93:#103 SA93:#225 Schwachman syndrome Selenium deficiency, 14:123 antibiotic prophylaxis, SA93:#1 30 clinical disorders of neutropenia, Self-esteem, conduct disorders and, cervical cancer and, 12:383(abs) 12:208 children and adolescents, 12:218 maternal, evaluation by diagnosis of celiac syndrome and, Sensorineural hearing loss, 14:43 pediatrician, 12:11, 291 12:325 Separation anxiety, 13:16 Shigella species, 13:283; SA93:#297 Screening, 14:297 Sepsis, 13:269; 14:262 Shingles, SA93:#234 developmental bacterial, clinical findings, Shock Bayley scales, SA92:#20 SA93:#1 97 cardiogenic Denver Development test, clinical disorders of neutropenia, in newborn, SA93:#89 SA92:#236 12: 208 signs and symptoms of, frequency of, SA92:#149 granulocyte transfusions and SA93:#1 29 developmental disabilities early neonates, 12:298 clinical signs of, SA93:#39

Pediatrics in Review Vol. 14 No. 12 December 1993 515 I .. ., . .. ., . .. I neurogenic, SA93:#1 16 Sonography, 13:334 congenital septic, SA93:#39 Sorbitol, diarrhea, 13:399(abs) characteristics of, SA92:#1 76, treatment of, SA92:#27, #93 Spasmodic croup, 14:19 #258 Short bowel syndrome, 13:185 Special education, 14:4 evaluation of, SA93:#93, #282 Short stature Speech Strychnine, 13:273 boys, 13:5(abs) and language problems, Sturge-Weber syndrome, SA93:# 134 causes of, SA92:#24 13: 1 19(abs) Subdural effusion, 14:11 genetic, growth hormone and, delayed, hearing impairment, Subcutaneous tumors, 13:371 12:355 SA92:#82 Subluxation, radial head dislocation, Shunt Spherocytosis, hereditary, SA92:#36 malfunction, 13:295 SA93:#1 39 Substance abuse, 13:314, 381; 14:380 ventriculoperitoneal, 13:295 Spinal cord, 14:364 alcohol, SA93:#90, #312 Shwachman-Diamond syndrome, dysfunction, SA92:#1 87 drugs, SA93:#112, #128, #312 SA93:#44 injury, SA93:#116 hallucinogens, SA93:#84 Skull fractures, 14:389 lesions, 14:117 heroin, SA92:#198 Sialadenitis, SA92:# 183 Spiramycin, toxoplasmosis and, narcotics, SA92:#69 Sibling rivalry, 13:72 12:227 screening, SA92:#19 Sickle cell Spirometry, SA92:#243 Sucking neonates, 14:123 disease, 13:33, 334 Spitz nevi, 13:371 Sudden Infant Death Syndrome, infections in, SA93:#276 Splenomegaly, 13:25, 55 14:51, 83, 94(abs), 100(abs) neurologic complications of, Spondylitis, ankylosing, 14:117 Suicide, 13:144; 14:380 SA93:#47 Sporotrichosis, 13:152 attempts, 14:380 pneumococcal vaccine, use of, Sports medicine, 13:474(abs); 14:424 Sulfasalazine, 14:475 SA93:#276 anabolic steroids, 12:103 Sulfonamide inheritance, 13:138 Sprain, ankle, 14:424 in cystitis, SA92:#88 Silver nitrate, 14:423 Stanozolol, angioedema, 13:387 prophylaxis, otitis, 13: 199(abs) Single photon emission computed Staphylococcal scalded skin Surface area, newborn, 13:262 tomography, 13:248 syndrome (5555), SA92:#89 Surfactant Sinusitis, 14:345 Staphylococcus replacement therapy, 12:261 acute aureus, SA93:#292 therapy, SA92:#270 complications of, SA92:#248 infection, 13:283 Surgery, SA93:#76 microbiology of, SA92:#1 46 osteomyelitis, 12:292 corticosteroids, 13:403 chronic Status epilepticus, 13:298 psychologic preparation of microbiology of, SA92:#281 Stealing, children and adolescents, children, 12:332(abs) immunodeficiency, 14:226 12:218 preparation, 13: 126(abs) infants and children, 12:217(abs) Steroids, 13:130; 14:30 Surgical abdomen in children, 14:302 Skeletal mineralization, 14:123 anabolic, 14:424; SA92:#92 Sweat, 14:424 Skin athletic performance and, 12:103 electrolytes, in cystic fibrosis, infections, streptococcal, Stillbirth, pediatrician’s response 13:183 SA93:#163 (commentary), 12:163 testing, SA92:#1 52 testing, allergy, SA93:#42 Stings, insect, SA92:# 167; Sympathetic nervous system, 14:489 SLE-See systemic lupus SA93:#21 8 Syncope, cardiac causes, 12:62(abs); erythematosus Stooling, frequency, in infants, 13:469 Sleep SA93:#1 46 Syndrome of inappropriate decreased ventilation, 13:473(abs) Storage disease, SA92:#1 64 antidiuretic hormone secretion disturbance, 13: 1 16(abs) Strabismus, 13:7 (SIADH), SA92:#38; SA93:#238 position, 14:83 and torticollis, 14:433 Synovitis problems, 13:16; SA93:#166 Streptococcal limping and, 12:268 Smog, asthma, 13:403 infections, 14:262 toxic, diagnosis, 12:292 Smoking, SA92:#32, #289 perianal disease, rectal bleeding Syphilis, 13:443; 14:180 asthma, 13:403 and, 12:248(abs) false-positive test in systemic Snoring, sleep apnea, 14:445 skin infections, SA93:#1 63 lupus, 14:281 Sodium Streptococcus serologic tests for, 14:281 balance, 14:70 group B, transmission, SA93:#73 Syrup of ipecac, SA93:#6 fractional excretion of, SA92:#84; pneumoniae, 14:320 Systemic lupus erythematosus, SA93:#1 27 clinical manifestations, 14:194, 281 total body, SA93:#1 27 SA93:#1 88 laboratory evaluation of, Sodium vaiproate, 13:298 pyogenes, 13:283 SA92:#132; SA93:#151 Soft neurologic signs, 13:231 Streptomycin, 13:343 diagnostic criteria, 14:281 Soiling, 14:447 Stress test, SA93:#30 juvenile dermatomyositis, 12:117 Solid food, introduction of, Stridor, 13:113; 14:19 neurologic involvement in, SA92:#299 and epiglottitis, SA92:#254 SA92:#1 1

516 Pediatrics in Review Vol. 14 No. 12 December 1993 F I T

Tachycardia, paroxysmal Thrombocytopenia, 13:163; 14:215, Toxoplasmosis supraventricular, 14:273 218; SA92:#130 congenital, complications of, Talipes equinovarus, SA92:#64 sepsis, 13:269 SA93:#1 1 Tanner stages, SA92:#58; systemic lupus erythematosus, risks to fetus, 12:227 SA93:#87 14:194 Tracheitis, 14:19 pubertal and psychosocial Thromboembolism, hemophilia and, Tracheoesophageal fistula, 13:50; development, 12:249 12:275 SA92:#1 39 Taurine requirements, preterm, Thrush, oral, SA93:#3 Tracheomalacia 14:123 Thumb sucking, 13:16 characteristics of, SA93:#59 Tay-Sachs disease, clinical findings, Thymic aplasia, 14:226 ventilation in, SA92:#189 in, SA93:#138 Thymus absence, 13: 197(abs) Transcranial Doppler imaging, Technetium bone scan, osteomyelitis, Thyroglossal duct cysts, 13:371; 13:248 12:292 14:48 1 Transfusions, 13:55 Television, 13:144 Thyroid -caused hepatitis, 13:245 Technetium scans, 13:279(abs) carcinoma 12:363(abs) granulocytes, neonates, 12:298 Technical tips cyst, SA92:#182 recombinant erythropoietin, 12:244 children’s medicine, 13:195 tumor, SA92:#182 Transient hypogammaglobulinemia, trapped penile foreskin, 14:140 Thyroiditis, 14:481 14:226 use of mannequins in training, Hashimoto, 14:481 Transient neonatal pustular 13 :244 lymphocytic, 14:481 melanosis, diagnosis of, Teenage pregnancy, 14:116(abs) Thyromegaly, 14:481 SA93:#1 84 Telogen effluvium, alopecia Tibial torsion, 14:395 Transillumination, 14:345 differentiation, 12:25 Ticarcillin, use of, SA93:#257 fiberoptic, 13:239(abs) Teratogens, 13:364 Tics, 13:37(abs) Transition to adulthood, 13:224 Teratogenesis, effects on fetus, Tinea Transplantation, liver, 14:436; 12:282 capitis, 13:152 SA93:#1 40 Teratogenic effects, rifampin, alopecia differentiation, 12:25 Tranquilizers, 13:381 13:354(abs) corporis, 13:152; SA93:#250 Trauma Terfenadine, 13:323 crusis, 13:152 chest, 14:237 Testes, torsion, 13:295 pedis, 13:152 eyes, 13:422 Testicles, abnormalities in Klinefelter versicolor, 13:152; SA93:#79 motor vehicle accident, syndrome, 13:435 Tobacco, 14:275; SA92:#257 SA92:#154, #251 Testicular smokeless, adolescents and, renal, SA92:#154 self-examination, 13:1 15(abs) 12:297(abs) spinal cord, 14:364; SA93:#116 torsion, 13:295; 14:302 Tocopherol, 13:185 splenic, SA92:#251 ofappendix, 13:295 Toileting program, 14:447 Traveler’s diarrhea, SA92:#1 71 tumor, 13: 1 15(abs) Tonsillar hypertrophy, SA92:#300 Treacher Collins syndrome, 14:473 Testosterone, therapy, 13:5(abs) cor pulmonale, 13:473(abs) Trendelenberg sign, 13:391 Tests, drug, SA92:#19 Tonsillopharyngitis, exudative, Trichomonas, 14:141 Tetanus SA93:#258 vaginalis, 13:443; 14:180 boosters, 13:257 Torticollis, 13:174; 14:433 Trichotillomania, alopecia vaccine, SA93:#1 25 congenital differentiation, 12:25 Tetany, 13:185 causes of, SA93:#1 80 Tricyclic antidepressants, 13:273; Tetracycline ophthalmic ointment, treatment of, SA92:# 159 14:411; SA92:#268 14:423 Total parenteral nutrition, Triglycerides Tetraology of Fallot, SA92:#1 17, SA92:#253 celiac disease and, 12:325 #169 Total quality management, 14:208 medium-chain, special infant Thalassemia 13:55 Tourette syndrome, 13:37(abs), formulas, 12:55 Thalidomide, effects on fetus, 12:282 460(abs); SA93:#204, #281 preterm, 14:123 Thelarche, pubertal and psychosocial Toxemia of pregnancy, 14: 1 16(abs) Trimethoprim-sulfamethoxazole, development, 12:249 Toxic exposures, 14:411 SA92:#1 71 Theophylline, 13:273, 403, 413; Toxicity Trisomy 21 , 14:488(abs) 14:411 anabolic steroids, 12:103 atlantoaxial dislocation in, hypoalbuminemia, effect on, chloramphenicol, SA92:#73, SA92:#147, #206 SA93:#21 9 #229 developmental disabilities, early toxicity of, SA93:#21 9 furosemide, SA92:#116 intervention, 12:305 drug interactions, 13:113 theophylline, SA92:#208 recurrence of, SA92:#85 Therapy, chronic, complications, Toxicology screening, urine, Tropical pediatrics, 14:95 SA92:#1 89 SA93:#1 2 Truancy, conduct disorders and, Thermoregulation, SA92:#244 children and adolescents, 12:218

Pediatrics in Review Vol. 14 No. 12 December 1993 517 I . i.:t;;’ :::. : I

Tiypsinogen deficiency, SA93:#44 Tuberous sclerosis, characteristics of, growth hormone and, 12:355 celiac disease and, 12:325 SA92:#21 6 kaiyotypes in, SA93:#208 Tube feeding, SA92:#279 Tumors Tympanocentesis, 14:320 composition of, SA93:# 157 ofskin, 13:371 Tympanogram, 14:320 Tuberculin test, 13:343 spinal cord, 14:364 Tympanometry, 13:355; 14:43; Tuberculosis, 13:343, 354(abs) Turner syndrome 13:43 SA93:#1 3 spinal cord, 14:364 characteristics of, SA92:#25 Tympanostomy tubes, 13:23, 355 transmission, 13:283 U

Ulcerative colitis, 14:352, 475 Urethral valves, posterior, SA93:#81 Urine treatment of, SA93:#1 6 Urethritis, 14:180; SA92:#90 drug testing, 13:314; SA93:#12 Ultrasonography, 13:32(abs), Urinary tract infection, 14:25 1 orange color, 13:354(abs) 49(abs), 248; 14:302 laboratory diagnosis of, Urologic problems, pelvic, 13:216 SA93:#1 41 myelomeningocele, 13:293(abs) prenatal, uses of, SA93:#54 microbiology of, SA93:#255 Urticaria, 13:387; SA93:#218 testicular torsion, 13:295 recurrent, and reflux, SA93:#31 1 pigmentosa, mimicking bruising, Umbilical catheterization, use of screening tests for, SA93:#1 41 14:215 mannequins in training, 13:244 treatment of, SA92:#88; Usher syndrome, 14:43 Umbilical cord care, 13:262 SA93:#269 Uteroplacental insufficiency, 13:262 Upper respiratory tract infections, Urination, newborn, 13:262 Uvula, bifid, 14:191 13:283 Uvulitis, SA92:#1 12

V

Vaccine leukemia and, 12:313 daily requirements for, in infants, diphtheria-tetanus toxoids with -zoster virus, 13:283; SA93:#234 SA93:#21 5 pertussis, 13:98; SA92:#54; immune globulin, SA93:#101 deficiency, SA92:#290 SA93:#125, #201, #221 Vascular ring, SA92:#258, #282 Vitamin E, preterm, 14:123 egg allergy, 14:245(abs) Vasculitis, 13:130 Vitamin K, 13:262; 14:265 Haemophilus influenzae, 13:98 as cause of purpura, 14:215 deficiency, breast-fed infants, hepatitis, 13:203, 245 juvenile dermatomyositis, 12:117 12:303(abs) hepatitis B, 13:203 VATER association, SA92:#5 in newborn, 14:191 influenza, 13:98; SA93:#68 Venous hum, clinical findings of, Vitamins, 13:185 measles, SA92:#1 10 SA93:#1 9 fat soluble, SA92:#143 meningococcal, 13:98 Ventilation, assisted, complications preterm, 14:123 MMR, DTP, and OPV, of chronic use, SA92:#1 89 Vitiligo, in Addison disease, 13:435 12:382(abs) Ventilation tube insertion, 14:320 Vocal cord pertussis, 13:98 Ventriculitis, 14:11 lesions, evaluation of, SA93:#246 pneumococcal, 13:98; SA93:#276 Ventriculoperitoneal shunt, 13:295 paralysis, SA92:#1 76 rubella, 13:98 Vermont Children’s Forum 13:64 Volvulus, 13:50 Vaginal Vertigo, SA92:#100; SA93:#170 Vomiting, 13:174; SA93:#110 bleeding, 14:141; SA92:#47 Very low-birth-weight infant, 14:123 bilious, in infant, SA92:#295; discharge, 13:443; 14:141 Vesicoureteral reflux, SA93:#31 1 SA93:#1 10 Vaginitis, 14:180 Violence, 13:144 in intussusception, 13:391 Vaginosis, 13:443 counseling, 12:68(abs) in meningitis, 14:155 Valium, febrile seizures, 13:298 Viral infections, development of newborn, 13:262 Valproic acid, 13:364 specific immunity, SA93:#214 recurrent, etiologies of, SA93:#71 Vancomycin, 13:413 Virotoxic E coli, 14:218 von Recklinghausen disease, 14:433 Vanillylmandelic acid, abdominal Virus identification, 14:25 1 von Willebrand disease, 13:163; masses, 12:196 Visual impairment, dyslexia, 13:231 SA92:#278 Varicella, 13:107 Vitamin A, 13:364 Vulnerable child syndrome, exposure to, SA93:#234 fetal effects, 12:282 SA92:#240 in immunocompromised, Vitamin B12, deficiency, SA93:#74 Vulvovaginitis, 14:141 SA93:#1 00 Vitamin D, 14:265

w

Walking, SA92:#284 in Addison disease, 13:435 Weight Warts, 13:371 in myasthenia gravis, 14:361 gain, 13:88 Water intoxication, 14: 1 1 , 103 Wechsler intelligence test, 13:231 in infant, SA93:#223, #315 Weakness, 13:113, 474(abs); 14:117 loss, sports, 14:424

518 Pediatrics in Review Vol. 14 No. 12 December 1993 I . I velocity in fetus, SA92:#246 Wilms tumor, 13:25; 14:169 bite, human, SA93:#1 79 Western blot, HIV, 14:38(abs) identification of, 12:196 care, 13:257 Wheezing, 13:403 pediatrician and (commentary), facial, SA93:#36 in congestive heart failure, 14:361 12:5 management of, tetanus localized, SA93:#285 Wilson disease, 14:436 prophylaxis, SA93:#1 25 recurrent, asthma, SA92:#193 Wiskott-Aldrich syndrome, 14:226 Writing reversals, 13:231 “Whiff” test, 14:141 Wounds bite, cat, SA93:#243

x

Xerophthalmia, 13:185 X-linked recessive disorders, 13:138

z

Zidovudine, 14:371 Zinc deficiency, 14:123 Zipper, release of foreskin, 14:140 hemophilia and, 12:275

This OflO

Pediatrics in Review VoL 14 No. 12 December 1993 I 519 TANQJT-CZBG \\ Anicricaii Academy :

of Pcdiatric S \

Continuing Education Programs

Annual Meeting

Dallas, Texas October 22-26, 1994

Spring Session Denver, Colorado April 23-27, 1994

Pediatric UPDATE Audio Tapes July 1993-June 1994 Selected topics include: . Management of Compromised Babies

. Adolescence - Interviewing Techniques

. Infectious Diseases - Tuberculosis

To enroll in Pediatric UPDATE, call or write: Pediatric UPDATE 2 Seaview Blvd. Port Washington, NY 11050-4618 800/847-0088

Continuing Medical Education Courses

Pediatric Update Clinical Advances in Pediatrics Williamsburg, Virginia Santa Fe, New Mexico December 10-12. 1993 May 13-15, 1994

Current Concepts in Pediatrics Pediatric Advances Vail, Colorado Hilton Head Island, South January 6-9, 1994 Carolina May 27-29, 1994 Pediatrics 1994 Orlando, Florida Clinical Pediatrics .1 March 18-20, 1994 Washington, DC June 17-19, 1994 State-of-the-Art Pediatrics New York, New York Practicing Pediatrics April 15-17, 1994 Huron, Ohio p August 12-14, 1994

PREP: THE COURSE

Hunt Valley, Maryland Phoenix, Arizona , May 7-1 1, 1994 September 24-28, 1994

For further information contact: American Academy of Pediatrics, CME Registration P0 Box 927 Elk Grove Village, IL 6(X)09-0927 i: 800/433-9016 or 708/228-5005

-/: :#{149}.- These programs feature subject matter coordinated with the PREP

:. curriculum. Credits earned may be applied toward the PREP Edu-

, . - 1; cation Award. , i

- .,.

!.-,:.,(.

. .